[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 606
1. Li BJ, Wang JY, Wang HY, Huang XP, Zhang LJ, Long H, Yang MT, Rong TH: [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient]. Zhonghua Zhong Liu Za Zhi; 2006 Oct;28(10):766-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
  • OBJECTIVE: To investigate the expression of the human mammoglobin (hMAM) mRNA in bone marrow and its clinical significance in the breast cancer patient.
  • METHODS: Expression of hMAM mRNA was detected using nested reverse transcription polymerase chain reaction (RT-PCR) in the bone marrow aspiration sample from 75 breast cancer patients, 15 patients with benign breast lesions and 8 healthy volunteers as control.
  • However, hMAM mRNA expression was not detected in the bone marrow aspiration samples from patients with benign breast lesions and healthy volunteers.
  • The hMAM mRNA expression was positively correlated with axillary nodal involvement and progesterone receptor (PR) status (P < 0.05) as well as Ki67 expression in breast cancer tissue (chi2 = 4.936, P = 0.026), but not with age, tumor size, clinical stage, or estrogen receptor (ER) status (P > 0.05).
  • CONCLUSION: RT-PCR is quite sensitive and has a high specificity in detecting the presence of hMAM mRNA in the bone marrow from breast cancer patients.
  • Thereupon, hMAM mRNA may be useful as a molecular biomarker in detecting disseminated tumor cells (DTC) in the bone marrow of breast cancer patients.
  • [MeSH-major] Bone Marrow / metabolism. Breast Neoplasms / genetics. Breast Neoplasms, Male / genetics. Neoplasm Proteins / genetics. Uteroglobin / genetics
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / genetics. Breast / metabolism. Breast / pathology. Carcinoma, Ductal, Breast / genetics. Carcinoma, Ductal, Breast / pathology. Female. Fibroadenoma / genetics. Fibroadenoma / pathology. Humans. Ki-67 Antigen / genetics. Lymphatic Metastasis. Male. Mammaglobin A. Middle Aged. RNA, Messenger / biosynthesis. RNA, Messenger / genetics. Receptors, Progesterone / genetics. Reverse Transcriptase Polymerase Chain Reaction

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Male Breast Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17366790.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Mammaglobin A; 0 / Neoplasm Proteins; 0 / RNA, Messenger; 0 / Receptors, Progesterone; 0 / SCGB2A2 protein, human; 9060-09-7 / Uteroglobin
  •  go-up   go-down


2. Morgan T, Atkins GJ, Trivett MK, Johnson SA, Kansara M, Schlicht SL, Slavin JL, Simmons P, Dickinson I, Powell G, Choong PF, Holloway AJ, Thomas DM: Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB. Am J Pathol; 2005 Jul;167(1):117-28
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB.
  • Giant cell tumor of bone (GCT) is a generally benign, osteolytic neoplasm comprising stromal cells and osteoclast-like giant cells.
  • [MeSH-major] Bone Neoplasms / genetics. Carrier Proteins / metabolism. Giant Cell Tumor of Bone / genetics. Membrane Glycoproteins / metabolism. Osteoclasts / metabolism
  • [MeSH-minor] Cell Differentiation / physiology. Cell Lineage. DNA Primers. Flow Cytometry. Gene Expression. Gene Expression Profiling. Histiocytoma, Benign Fibrous / genetics. Humans. Immunohistochemistry. Leiomyosarcoma / genetics. Liposarcoma / genetics. Nucleic Acid Hybridization. Proteins / analysis. RANK Ligand. RNA, Messenger / analysis. Receptor Activator of Nuclear Factor-kappa B. Reverse Transcriptase Polymerase Chain Reaction. Sarcoma, Synovial / genetics

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Bone. 1999 Nov;25(5):525-34 [10574572.001]
  • [Cites] Cancer Genet Cytogenet. 1993 Jul 1;68(1):1-21 [8330278.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1566-71 [10677500.001]
  • [Cites] Am J Pathol. 2000 Mar;156(3):761-7 [10702390.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Apr 21;270(3):1124-7 [10772961.001]
  • [Cites] J Bone Miner Res. 2000 Apr;15(4):640-9 [10780856.001]
  • [Cites] Endocr Rev. 2000 Aug;21(4):393-411 [10950158.001]
  • [Cites] Mod Pathol. 2000 Nov;13(11):1206-10 [11106078.001]
  • [Cites] Arthritis Res. 2000;2(6):451-456 [11094458.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 May 8;98(10):5798-803 [11331755.001]
  • [Cites] J Biol Chem. 2001 Mar 9;276(10):7376-82 [11084030.001]
  • [Cites] Nat Med. 2001 Jun;7(6):673-9 [11385503.001]
  • [Cites] Int J Cancer. 2001 Sep15;93(6):769-72 [11519035.001]
  • [Cites] J Bone Miner Res. 2001 Oct;16(10):1747-9 [11585336.001]
  • [Cites] Nat Genet. 2001 Nov;29(3):263-4 [11687795.001]
  • [Cites] Am J Clin Pathol. 2002 Feb;117(2):210-6 [11863217.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4477-82 [11930005.001]
  • [Cites] Lancet. 2002 Apr 13;359(9314):1301-7 [11965276.001]
  • [Cites] Nat Med. 2002 Sep;8(9):995-1003 [12185361.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12963-8 [12297621.001]
  • [Cites] Hum Pathol. 2003 Jan;34(1):65-73 [12605368.001]
  • [Cites] Nature. 2003 May 15;423(6937):337-42 [12748652.001]
  • [Cites] J Oral Pathol Med. 2003 Jul;32(6):367-75 [12787044.001]
  • [Cites] J Bone Miner Res. 2003 Jun;18(6):1088-98 [12817763.001]
  • [Cites] Am J Pathol. 2003 Aug;163(2):691-700 [12875988.001]
  • [Cites] Biochem Biophys Res Commun. 2003 Aug 8;307(4):1051-8 [12878218.001]
  • [Cites] Gene. 2003 Oct 16;316:23-32 [14563548.001]
  • [Cites] FEBS Lett. 2003 Oct 23;553(3):257-61 [14572634.001]
  • [Cites] Hum Pathol. 2003 Oct;34(10):983-93 [14608531.001]
  • [Cites] N Engl J Med. 2003 Dec 25;349(26):2483-94 [14695408.001]
  • [Cites] Mol Endocrinol. 2004 May;18(5):1222-37 [14976225.001]
  • [Cites] Cancer Genet Cytogenet. 1993 Dec;71(2):132-8 [8281516.001]
  • [Cites] J Bone Miner Res. 1994 Jul;9(7):1013-20 [7942147.001]
  • [Cites] Bone. 1995 Aug;17(2):111-9 [8554918.001]
  • [Cites] J Bone Miner Res. 1996 Oct;11(10):1453-60 [8889845.001]
  • [Cites] J Biol Chem. 1996 Dec 20;271(51):33141-7 [8955163.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602 [9520411.001]
  • [Cites] Stem Cells. 1998;16(3):229-38 [9617898.001]
  • [Cites] Nature. 1999 Jan 28;397(6717):315-23 [9950424.001]
  • [Cites] J Bone Miner Res. 2004 Dec;19(12):2065-77 [15537451.001]
  • [Cites] Cell. 1997 Apr 18;89(2):309-19 [9108485.001]
  • [Cites] J Biol Chem. 2002 Dec 13;277(50):48808-15 [12374791.001]
  • [Cites] Bone. 2004 May;34(5):827-34 [15121014.001]
  • [Cites] Protein Expr Purif. 2004 Sep;37(1):47-52 [15294280.001]
  • [Cites] J Clin Invest. 2004 Aug;114(4):475-84 [15314684.001]
  • [Cites] J Bone Miner Res. 2004 Nov;19(11):1873-81 [15476588.001]
  • [Cites] J Clin Invest. 1987 Feb;79(2):483-91 [3027126.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Mar;87(5):1663-7 [1689846.001]
  • [Cites] Cancer Genet Cytogenet. 1992 Jan;58(1):2-13 [1728946.001]
  • [Cites] Bone Miner. 1992 Jan;16(1):37-48 [1531620.001]
  • [Cites] Cancer. 1993 Mar 1;71(5):1751-60 [8095436.001]
  • [Cites] J Histochem Cytochem. 1993 Jul;41(7):1075-83 [8515049.001]
  • [Cites] Pathology. 1999 Nov;31(4):373-8 [10643009.001]
  • (PMID = 15972958.001).
  • [ISSN] 0002-9440
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Carrier Proteins; 0 / DNA Primers; 0 / Membrane Glycoproteins; 0 / Proteins; 0 / RANK Ligand; 0 / RNA, Messenger; 0 / Receptor Activator of Nuclear Factor-kappa B; 0 / TNFRSF11A protein, human; 0 / TNFSF11 protein, human
  • [Other-IDs] NLM/ PMC1603441
  •  go-up   go-down


3. Franceschi F, Marinozzi A, Rizzello G, Papalia R, Rojas M, Denaro V: Computed tomography-guided and arthroscopically controlled en bloc retrograde resection of a juxta-articular osteoid osteoma of the tibial plateau. Arthroscopy; 2005 Mar;21(3):351-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoid osteoma represents approximately 10% to 11% of all the benign bone tumors.
  • The lesion was removed by a rear-entry computed tomography (CT)-guided drill under arthroscopic control and the bony defect filled with bone graft harvested from the proximal tibial metaphysis.
  • The follow-up CT scan 2 years after surgery showed complete excision of the lesion and perfect positioning of the bone graft.
  • [MeSH-major] Arthroscopy / methods. Bone Neoplasms / surgery. Knee Joint / surgery. Osteoma, Osteoid / radiography. Osteoma, Osteoid / surgery. Tibia / surgery. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15756191.001).
  • [ISSN] 1526-3231
  • [Journal-full-title] Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association
  • [ISO-abbreviation] Arthroscopy
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


Advertisement
4. Sim IW, Tse LF, Ek ET, Powell GJ, Choong PF: Salvaging the limb salvage: management of complications following endoprosthetic reconstruction for tumours around the knee. Eur J Surg Oncol; 2007 Aug;33(6):796-802
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Salvaging the limb salvage: management of complications following endoprosthetic reconstruction for tumours around the knee.
  • INTRODUCTION: Limb-salvage surgery, including endoprosthetic reconstruction after tumour resection, has become the standard management for local control of tumours around the knee.
  • METHODS: Retrospective analysis of consecutive resections and endoprosthetic reconstructions for tumours around the knee between 1996 and September 2005 performed at St Vincent's Hospital, Melbourne.
  • Tumour types included 38 primary musculoskeletal malignancies, 8 metastatic tumours, 2 bony lymphomas and 2 benign lesions.
  • CONCLUSION: Resection and endoprosthetic reconstruction of tumours around the knee is both technically challenging and resource-intensive.
  • [MeSH-minor] Adolescent. Adult. Aged. Amputation. Bone Neoplasms / surgery. Female. Follow-Up Studies. Humans. Intraoperative Complications. Joint Prosthesis. Male. Middle Aged. Muscle Neoplasms / surgery. Neoplasm Metastasis. Popliteal Artery / injuries. Postoperative Complications. Prosthesis Failure. Reoperation. Retrospective Studies. Surgical Wound Infection / etiology. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Joint Disorders.
  • MedlinePlus Health Information. consumer health - Knee Replacement.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17291709.001).
  • [ISSN] 0748-7983
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


5. Sadeghi-Azandaryani M, Mendl N, Rademacher A, Hoffmann U, Steckmeier B, Heyn J: Pseudoaneurysm of the popliteal artery due to osteochondroma of the distal femur. Vasa; 2010 Aug;39(3):274-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteochondroma is the most common type of benign bone tumour, and is most often found in the knee region.
  • The lesion is usually clinically silent although it may cause different complications such as fractures of the tumour, bone deformities, neurological disorders, malignant transformation and in rare cases vascular disorders.
  • A delay in diagnosis especially of pseudoaneurysm formation may result in life-threatening situations, extensive operations and lengthy hospital stays.

  • Genetic Alliance. consumer health - Osteochondroma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20737389.001).
  • [ISSN] 0301-1526
  • [Journal-full-title] VASA. Zeitschrift für Gefässkrankheiten
  • [ISO-abbreviation] VASA
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


6. Mackenzie H, Gulati V, Tross S: A rare case of a swollen knee due to disseminated synovial chondromatosis: a case report. J Med Case Rep; 2010;4:113
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: A synovial chondromatosis is a rare benign neoplasm on the synovium.
  • Although described as a benign disease, it can be very destructive and can cause severe osteoarthritis and pain.
  • CONCLUSIONS: Although synovial chondromatosis is described as a benign disease, it can be very destructive and debilitating.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Arthroplasty. 2008 Apr;23(3):395-400 [18358378.001]
  • [Cites] J Bone Joint Surg Am. 1973 Dec;55(8):1747-8 [4804995.001]
  • [Cites] J Bone Joint Surg Am. 2007 Jun;89(6):1321-8 [17545437.001]
  • (PMID = 20416049.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2873448
  •  go-up   go-down


7. Geniets C, Vanhoenacker FM, Van de Perre S, Van Dyck P, Gielen J, De Schepper AM, Parizel PM: Proceedings of the European Society of Musculoskeletal Radiology (ESSR) training module, Antwerp, 20-21.01.05. Part two: bone tumors. Benign bone lesions: characteristic imaging features. JBR-BTR; 2006 Sep-Oct;89(5):266-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Proceedings of the European Society of Musculoskeletal Radiology (ESSR) training module, Antwerp, 20-21.01.05. Part two: bone tumors. Benign bone lesions: characteristic imaging features.
  • Benign bone lesions are a fairly common finding in radiology practice.
  • Often, the combination of patient's age and plain radiographic findings are sufficient for diagnosis and obviates the need for further imaging.
  • Generally the following parameters should be assessed in the evaluation of a bone lesion: clinical features, age of the patient, location, size, pattern of bone destruction, cortical involvement, zone of transition, sclerotic margination and matrix calcification.
  • This article reviews the spectrum of clinical and imaging appearances of the most common benign bone tumors.
  • [MeSH-major] Bone Diseases / diagnosis. Bone Neoplasms / diagnosis. Magnetic Resonance Imaging. Radiology. Societies, Medical. Tomography, X-Ray Computed
  • [MeSH-minor] Bone and Bones / pathology. Humans

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Bone Diseases.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17147017.001).
  • [ISSN] 0302-7430
  • [Journal-full-title] JBR-BTR : organe de la Société royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)
  • [ISO-abbreviation] JBR-BTR
  • [Language] eng
  • [Publication-type] Congresses
  • [Publication-country] Belgium
  •  go-up   go-down


8. Skubitz KM, Manivel JC: Giant cell tumor of the uterus: case report and response to chemotherapy. BMC Cancer; 2007;7:46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant cell tumor of the uterus: case report and response to chemotherapy.
  • BACKGROUND: Giant cell tumor (GCT) is usually a benign but locally aggressive primary bone neoplasm in which monocytic macrophage/osteoclast precursor cells and multinucleated osteoclast-like giant cells infiltrate the tumor.
  • The etiology of GCT is unknown, however the tumor cells of GCT have been reported to produce chemoattractants that can attract osteoclasts and osteoclast precursors.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Giant Cell Tumors / drug therapy. Uterine Neoplasms / drug therapy
  • [MeSH-minor] Angiogenesis Inhibitors / administration & dosage. Antibiotics, Antineoplastic / administration & dosage. Antibodies, Monoclonal / administration & dosage. Antibodies, Monoclonal, Humanized. Antineoplastic Agents, Alkylating / administration & dosage. Bevacizumab. Combined Modality Therapy. Doxorubicin / administration & dosage. Female. Humans. Hysterectomy. Ifosfamide / administration & dosage. Lung Neoplasms / diagnosis. Lung Neoplasms / drug therapy. Lung Neoplasms / secondary. Middle Aged. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 1992 Feb;158(2):331-4 [1729794.001]
  • [Cites] APMIS Suppl. 1991;23:113-8 [1883635.001]
  • [Cites] Cancer. 1993 Nov 15;72(10):2963-9 [8221562.001]
  • [Cites] Clin Orthop Relat Res. 1994 May;(302):219-30 [8168305.001]
  • [Cites] Am J Clin Oncol. 1995 Apr;18(2):144-8 [7900706.001]
  • [Cites] Pathol Int. 1996 Sep;46(9):656-60 [8905874.001]
  • [Cites] Clin Orthop Relat Res. 1997 Feb;(335):253-61 [9020226.001]
  • [Cites] J Clin Oncol. 1997 Jun;15(6):2378-84 [9196153.001]
  • [Cites] Cell. 1998 Apr 17;93(2):165-76 [9568710.001]
  • [Cites] Surg Neurol. 1998 May;49(5):547-52 [9586934.001]
  • [Cites] J Cell Biochem. 1998 Jul 1;70(1):121-9 [9632113.001]
  • [Cites] J Clin Oncol. 1998 Jul;16(7):2445-51 [9667262.001]
  • [Cites] Int Orthop. 1998;22(3):200-4 [9728318.001]
  • [Cites] Pediatrics. 1999 Jun;103(6 Pt 1):1282-3 [10353942.001]
  • [Cites] Rev Chir Orthop Reparatrice Appar Mot. 1999 Jun;85(3):293-6 [10422135.001]
  • [Cites] J Exp Med. 1999 Jul 19;190(2):293-8 [10432291.001]
  • [Cites] J Cancer Res Clin Oncol. 1999 Oct;125(10):577-81 [10473871.001]
  • [Cites] Cancer. 2005 Jul 15;104(2):361-6 [15948172.001]
  • [Cites] J Clin Oncol. 2001 Aug 1;19(15):3483-9 [11481354.001]
  • [Cites] Am J Clin Pathol. 2002 Feb;117(2):210-6 [11863217.001]
  • [Cites] Cancer. 2002 Jun 15;94(12):3225-9 [12115355.001]
  • [Cites] Clin Orthop Relat Res. 2002 Aug;(401):202-8 [12151897.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Oct;60(10):1103-11; discussion 1111-3 [12378481.001]
  • [Cites] Cancer Invest. 2003 Apr;21(2):167-76 [12743981.001]
  • [Cites] Life Sci. 2003 Aug 1;73(11):1427-36 [12850503.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):158-65 [12909228.001]
  • [Cites] Br J Surg. 2004 Feb;91(2):242-7 [14760675.001]
  • [Cites] Orthopade. 2004 Mar;33(3):344-8 [15007559.001]
  • [Cites] Skeletal Radiol. 2004 May;33(5):295-9 [14997349.001]
  • [Cites] J Lab Clin Med. 2004 Aug;144(2):78-91 [15322502.001]
  • [Cites] Clin Orthop Relat Res. 2004 Sep;(426):32-8 [15346048.001]
  • [Cites] Clin Orthop Relat Res. 2004 Sep;(426):103-9 [15346059.001]
  • [Cites] Clin Cancer Res. 2004 Sep 1;10(17):5732-40 [15355900.001]
  • [Cites] Calcif Tissue Int. 2004 Jul;75(1):71-7 [15037971.001]
  • [Cites] J Lab Clin Med. 2004 Oct;144(4):193-200 [15514587.001]
  • [Cites] Cancer. 1968 Aug;22(2):333-44 [5660199.001]
  • [Cites] Endocrinology. 1972 Oct;91(4):916-20 [5051344.001]
  • [Cites] Cancer. 1973 Mar;31(3):621-5 [4693590.001]
  • [Cites] Cancer. 1975 Aug;36(2):495-504 [50874.001]
  • [Cites] Science. 1975 Nov 21;190(4216):784-5 [1105786.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1976 Sep 21;371(3):199-217 [184582.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1981 Mar;89(2):179-84 [7270164.001]
  • [Cites] Cancer. 1981 Nov 1;48(9):2022-8 [7296510.001]
  • [Cites] Arkh Patol. 1983;45(2):78-82 [6847417.001]
  • [Cites] J Bone Joint Surg Am. 1985 Jul;67(6):890-900 [4019539.001]
  • [Cites] Nature. 1999 Nov 18;402(6759):304-9 [10580503.001]
  • [Cites] Am J Pathol. 2000 Mar;156(3):761-7 [10702390.001]
  • [Cites] J Bone Miner Res. 2000 Apr;15(4):640-9 [10780856.001]
  • [Cites] Hum Pathol. 2000 Jul;31(7):804-12 [10923916.001]
  • [Cites] Eur J Cancer. 2001 May;37(7):870-7 [11313175.001]
  • [Cites] J Pathol. 1985 Nov;147(3):153-8 [4067733.001]
  • [Cites] Gynecol Oncol. 1986 Mar;23(3):381-6 [3957125.001]
  • [Cites] J Clin Invest. 1987 Feb;79(2):483-91 [3027126.001]
  • [Cites] Clin Orthop Relat Res. 1988 Dec;(237):275-85 [3056645.001]
  • [Cites] Clin Orthop Relat Res. 1989 Jun;(243):208-15 [2656024.001]
  • [Cites] Cancer. 1990 Apr 15;65(8):1838-42 [2317762.001]
  • [Cites] J Cancer Res Clin Oncol. 1993;119(5):301-3 [8440744.001]
  • (PMID = 17359524.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antibiotics, Antineoplastic; 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Antineoplastic Agents, Alkylating; 2S9ZZM9Q9V / Bevacizumab; 80168379AG / Doxorubicin; UM20QQM95Y / Ifosfamide
  • [Number-of-references] 57
  • [Other-IDs] NLM/ PMC1832205
  •  go-up   go-down


9. Faitaroni LA, Bueno MR, De Carvalhosa AA, Bruehmueller Ale KA, Estrela C: Ameloblastoma suggesting large apical periodontitis. J Endod; 2008 Feb;34(2):216-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • After the initial endodontic treatment, continued expansion of the mandible cortical bone was observed, indicating a need to surgically enucleate the lesion and submit it for histopathologic examination.
  • The microscopic examination indicated a diagnosis of ameloblastoma.
  • Ameloblastoma is a benign epithelial neoplasm of odontogenic origin, and depending on the stage of development, it can mimic a periapical lesion and therefore should be considered in establishing an endodontic differential diagnosis.
  • The definitive diagnosis for some periapical lesions can only be made by a histopathologic examination.
  • [MeSH-major] Ameloblastoma / diagnosis. Mandibular Neoplasms / diagnosis. Periapical Periodontitis / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Disease Progression. Follow-Up Studies. Humans. Male. Mandibular Diseases / diagnosis. Middle Aged. Root Canal Therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18215686.001).
  • [ISSN] 0099-2399
  • [Journal-full-title] Journal of endodontics
  • [ISO-abbreviation] J Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Khan N, Oriuchi N, Yoshizaki A, Kanuma T, Higuchi T, Endo K: Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer. Ann Nucl Med; 2005 Apr;19(2):137-45
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: This study evaluated the diagnostic role and accuracy of positron emission tomography (PET) using 2-[F-18]fluoro-2-deoxy-D-glucose (FDG) for the detection of tumor foci in patients with suspected recurrent or metastatic lesions of gynecologic cancers.
  • Malignant lesions accumulated significantly more FDG than the benign ones (the mean SUVs were 3.7 +/- 1.9 and 1.6 +/- 1.1, respectively, p = 0.004).
  • The sensitivity and specificity in correct identification of tumor recurrence or metastases using a threshold SUV 1.9 were 88.8% and 66.7% in contrast to the visual analysis (sensitivity 96.4%, specificity 50%) on a lesion-based analysis.
  • The partial volume effect of SUV in a few small lesions and the presence of bone lesions in which FDG uptake was relatively low might be the reason for the lower sensitivity in SUV analysis.
  • FDG PET was valuable when CT/MRI was negative or inconclusive, and in patients with elevated tumor marker levels as well as with normal tumor marker levels when recurrence was suspected clinically.
  • However, PET failed to visualize some small metastatic lesions in lung and bone, and showed falsely high FDG uptake in some benign lesions.
  • [MeSH-major] Carcinoma / radionuclide imaging. Carcinoma / secondary. Fluorodeoxyglucose F18. Genital Neoplasms, Female / radionuclide imaging. Genital Neoplasms, Female / secondary. Neoplasm Recurrence, Local / radionuclide imaging. Positron-Emission Tomography / methods

  • Genetic Alliance. consumer health - Metastatic cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15909494.001).
  • [ISSN] 0914-7187
  • [Journal-full-title] Annals of nuclear medicine
  • [ISO-abbreviation] Ann Nucl Med
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


11. Vallicioni J, Loum B, Dassonville O, Poissonnet G, Ettore F, Demard F: [Ameloblastomas]. Ann Otolaryngol Chir Cervicofac; 2007 Sep;124(4):166-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: The aim of this work was to report on the clinical, radiological and histological characteristics of ameloblastomas concerning bone structures of the face, rare but not exceptional tumours, and to communicate our experience of their treatment.
  • The diagnostic context, the treatment and the development of the disease are given in detail, emphasizing the frequency of local relapse of this histologically benign condition.
  • The frequency of local relapse in the cases of close resection, leaving in place micro-foci, justifies enlarged intervention, which is often bone destructive.
  • CONCLUSION: When the continuity of the bone is interrupted, in particular at the level of the mandible, and if the general condition of the patient permits, repair is preferable.
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17673157.001).
  • [ISSN] 0003-438X
  • [Journal-full-title] Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Société d'oto-laryngologie des hôpitaux de Paris
  • [ISO-abbreviation] Ann Otolaryngol Chir Cervicofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


12. Nguyen QH, Szeto E, Mansberg R, Mansberg V: Paravertebral infection (phlegmon) demonstrated by FDG dual-head coincidence imaging in a patient with multiple malignancies. Clin Nucl Med; 2005 Apr;30(4):241-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 66-year-old woman was referred for a bone scan to assess back pain on a background of breast cancer, melanoma, and rheumatic heart disease.
  • The scan appearance was suspicious for a localized soft tissue neoplasm.
  • Because FDG is not tumor-specific, accumulation in benign lesions may give rise to false-positive results despite a high pretest probability for malignancy.
  • [MeSH-minor] Aged. Back Pain / diagnosis. Back Pain / etiology. Breast Neoplasms / complications. Breast Neoplasms / radionuclide imaging. Diagnosis, Differential. Female. Gamma Cameras. Humans. Melanoma / complications. Melanoma / radionuclide imaging. Radiopharmaceuticals

  • MedlinePlus Health Information. consumer health - Cellulitis.
  • MedlinePlus Health Information. consumer health - Staphylococcal Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15764879.001).
  • [ISSN] 0363-9762
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


13. Buchner M, Bernd L, Zahlten-Hinguranage A, Sabo D: [Bone and soft-tissue tumors of the foot and ankle]. Chirurg; 2005 Apr;76(4):391-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bone and soft-tissue tumors of the foot and ankle].
  • [Transliterated title] Knochen- und Weichteiltumoren des Fusses und Sprunggelenkes Epidemiologie, Versorgungsstrategie und klinisch-funktionelle Ergebnisse nach operativer Therapie.
  • BACKGROUND: This study reports the epidemiology of bone and soft-tissue tumors of the foot and ankle, presents therapy strategies, and evaluates mid-term clinicofunctional outcome after surgery for malignant tumors.
  • METHODS: Two hundred four patients with tumors of the foot and ankle were analyzed (163 benign and 41 malignant).
  • RESULTS: The most frequent tumors were exostosis, bone cyst, and osteoid osteoma for benign tumors and metastases and chondrosarcoma and Ewing's sarcoma for malignant tumors.
  • In more than 90% of the benign tumors, local resection could be carried out, whereas in malignant tumors, ablative procedures and arthrodeses were almost as common as limb- and joint-sparing techniques.
  • However, follow-up revealed good functional results and a 5-year survival rate of 84% for patients with primary malignant tumors.
  • CONCLUSION: Tumors of the foot and ankle require a thorough therapeutic strategy.
  • [MeSH-major] Ankle Joint / surgery. Bone Neoplasms / surgery. Foot / surgery. Foot Diseases / surgery. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Amputation. Arthrodesis. Bone Transplantation. Child. Child, Preschool. Female. Follow-Up Studies. Fracture Fixation, Internal. Fractures, Spontaneous / diagnosis. Fractures, Spontaneous / surgery. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Staging. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Foot Health.
  • MedlinePlus Health Information. consumer health - Foot Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Am. 1980 Sep;62(6):1027-30 [7000786.001]
  • [Cites] Clin Orthop Relat Res. 1997 Oct;(343):173-82 [9345223.001]
  • [Cites] J Bone Joint Surg Am. 1989 Apr;71(4):621-6 [2703521.001]
  • [Cites] Cancer. 1997 Jul 1;80(1):50-9 [9210708.001]
  • [Cites] Clin Podiatr Med Surg. 1993 Oct;10(4):581-607 [8221541.001]
  • [Cites] Z Orthop Ihre Grenzgeb. 2003 Jul-Aug;141(4):445-51 [12929003.001]
  • [Cites] J Pediatr Orthop B. 1998 Jul;7(3):239-42 [9702678.001]
  • [Cites] Foot Ankle Int. 1994 Apr;15(4):175-81 [7951950.001]
  • [Cites] Foot Ankle. 1989 Oct;10 (2):68-80 [2807109.001]
  • [Cites] J Foot Ankle Surg. 1997 Sep-Oct;36(5):375-80; discussion 396 [9356917.001]
  • [Cites] Clin Orthop Relat Res. 1993 Jan;(286):241-6 [8425352.001]
  • [Cites] Foot Ankle. 1989 Dec;10 (3):147-51 [2613126.001]
  • [Cites] Chir Organi Mov. 1991 Jan-Mar;76(1):47-62 [1893786.001]
  • [Cites] J Foot Ankle Surg. 1997 Nov-Dec;36(6):403-8 [9429992.001]
  • [Cites] Clin Orthop Relat Res. 1993 Oct;(295):226-38 [8403653.001]
  • (PMID = 15526178.001).
  • [ISSN] 0009-4722
  • [Journal-full-title] Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
  • [ISO-abbreviation] Chirurg
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


14. Li BJ, Huang XP, Wei WD, Wang JY, Su XD, Zhang X, Hong WS, Tang J, Zhang LJ, Long H, Yang MT, Rong TH: [Expression and clinical significance of cytokeratin 19 in bone marrow of patients with breast cancer]. Ai Zheng; 2005 Jun;24(6):735-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression and clinical significance of cytokeratin 19 in bone marrow of patients with breast cancer].
  • Distant metastasis, especially bone metastasis, may influence prognosis of breast cancer patients.
  • Bone marrow micrometastasis (BMM) is difficult to detect with routine methods.
  • This study was designed to evaluate expression and clinical significance of cytokeratin 19 (CK19) in bone marrow of patients with breast cancer.
  • METHODS: Expression of CK19 mRNA in bone marrows of 65 breast cancer patients, 15 benign breast disease patients, and 8 healthy volunteers was detected by reverse transcription-polymerase chain reaction (RT-PCR).
  • RESULTS: Positive rate of CK19 mRNA was 33.8% in the 65 breast cancer patients, and 0 in both benign breast disease patients and healthy volunteers.
  • Expression of CK19 mRNA was positively correlated with tumor size and clinical stage (P < 0.05), but was not related to age and lymph node status (P > 0.05).
  • CONCLUSIONS: CK19 mRNA may be used as a molecular marker to detect bone marrow micrometastasis in patients with breast cancer.
  • [MeSH-major] Bone Marrow / metabolism. Breast Neoplasms / metabolism. Carcinoma, Ductal, Breast / metabolism. Keratin-19 / biosynthesis
  • [MeSH-minor] Adult. Aged. Breast Neoplasms, Male / metabolism. Breast Neoplasms, Male / pathology. Carcinoembryonic Antigen / blood. Female. Fibroadenoma / blood. Fibroadenoma / metabolism. Fibroadenoma / pathology. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. RNA, Messenger / biosynthesis. RNA, Messenger / genetics

  • Genetic Alliance. consumer health - Bone Cancer.
  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15946491.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Carcinoembryonic Antigen; 0 / Keratin-19; 0 / RNA, Messenger
  •  go-up   go-down


15. Moh EN, Aguehoundé C, Aké YL, Kéita A, Kotaix L: [Reconstruction using non-vascularized fibula of an aneurysmal bone cyst of the humerus in a child]. Mali Med; 2010;25(1):64-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Reconstruction using non-vascularized fibula of an aneurysmal bone cyst of the humerus in a child].
  • [Transliterated title] Reconstruction par Fibula non Vascularisee d'un Kyste Osseux Anevrysmal de L'Humerus Chez L'Enfant.
  • Aneurysmal bone cyst is a pseudotumoral bone dystrophy which accounts for 1.5 to 4% of benign bone tumours.
  • [MeSH-major] Bone Cysts, Aneurysmal / surgery. Fibula / transplantation. Humerus / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21436008.001).
  • [ISSN] 1993-0836
  • [Journal-full-title] Le Mali médical
  • [ISO-abbreviation] Mali Med
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Mali
  •  go-up   go-down


16. Luther N, Bilsky MH, Härtl R: Giant cell tumor of the spine. Neurosurg Clin N Am; 2008 Jan;19(1):49-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant cell tumor of the spine.
  • Giant cell tumors are benign but locally aggressive neoplasms that typically affect the extremities.
  • When involving the spine, the tumors occur predominantly in the sacrum.
  • Gross total resection of the tumor with wide margins yields good results in terms of survival.
  • Endovascular tumor embolizations have also been attempted to control unresectable tumors, and have been performed with moderate degrees of success.
  • Outcomes are analyzed outcomes following surgery, radiation therapy, and tumor embolization.
  • [MeSH-major] Giant Cell Tumor of Bone / pathology. Giant Cell Tumor of Bone / therapy. Spinal Neoplasms / pathology. Spinal Neoplasms / therapy. Spine / pathology
  • [MeSH-minor] Embolization, Therapeutic / methods. Humans. Neoplasm Recurrence, Local / prevention & control. Neoplasm Recurrence, Local / therapy. Neurosurgical Procedures / methods. Radiotherapy / methods. Spinal Cord Compression / etiology. Spinal Cord Compression / physiopathology. Spinal Cord Compression / surgery. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18156047.001).
  • [ISSN] 1558-1349
  • [Journal-full-title] Neurosurgery clinics of North America
  • [ISO-abbreviation] Neurosurg. Clin. N. Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 29
  •  go-up   go-down


17. von Falck C, Rosenthal H, Gratz KF, Galanski M: Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT. Clin Nucl Med; 2007 Aug;32(8):640-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, findings in the coregistered CT scan were consistent with nonossfiying fibroma, a common benign skeletal lesion.
  • Combined PET/CT imaging can be helpful to identify benign bone lesions mimicking metastatic or residual disease in F-18 FDG PET as illustrated by this case.
  • [MeSH-major] Femoral Neoplasms / diagnosis. Fibroma / radionuclide imaging. Fluorodeoxyglucose F18. Hodgkin Disease / diagnosis. Lymphoma / diagnosis. Positron-Emission Tomography / methods. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Antineoplastic Agents / therapeutic use. Child. Diagnosis, Differential. False Positive Reactions. Female. Humans. Image Enhancement / methods. Neoplasm Recurrence, Local / prevention & control. Neoplasm Recurrence, Local / radionuclide imaging. Radiopharmaceuticals. Subtraction Technique

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17667441.001).
  • [ISSN] 0363-9762
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


18. Saglik Y, Altay M, Unal VS, Basarir K, Yildiz Y: Manifestations and management of osteochondromas: a retrospective analysis of 382 patients. Acta Orthop Belg; 2006 Dec;72(6):748-55
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteochondromas represent the most common primary bone tumours; they reportedly represent 20-50% of all benign bone tumours and 10-15% of all bone tumours.
  • [MeSH-major] Bone Neoplasms / diagnosis. Bone Neoplasms / surgery. Osteochondroma / diagnosis. Osteochondroma / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Exostoses, Multiple Hereditary / complications. Exostoses, Multiple Hereditary / diagnosis. Exostoses, Multiple Hereditary / surgery. Female. Humans. Male. Middle Aged. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17260614.001).
  • [ISSN] 0001-6462
  • [Journal-full-title] Acta orthopaedica Belgica
  • [ISO-abbreviation] Acta Orthop Belg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


19. Azorín D, González-Mediero I, Colmenero I, De Prada I, López-Barea F: Diaphyseal chondroblastoma in a long bone: first report. Skeletal Radiol; 2006 Jan;35(1):49-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diaphyseal chondroblastoma in a long bone: first report.
  • Chondroblastoma is a rare benign bone tumor typically located in the epiphysis.
  • We describe the first case of chondroblastoma arising in the diaphysis of a long bone.

  • Genetic Alliance. consumer health - Chondroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Am. 1985 Jun;67(5):748-55 [3997927.001]
  • [Cites] Clin Orthop Relat Res. 1973 Sep;(95):300-12 [4585180.001]
  • [Cites] J Bone Joint Surg Am. 1974 Mar;56(2):413-5 [4452700.001]
  • [Cites] Ital J Orthop Traumatol. 1986 Dec;12(4):455-60 [3610613.001]
  • [Cites] Skeletal Radiol. 1985;14 (1):1-9 [4023729.001]
  • [Cites] Skeletal Radiol. 1986;15(5):387-90 [3738543.001]
  • [Cites] J Pathol. 2004 Jan;202(1):113-20 [14694528.001]
  • [Cites] J Bone Joint Surg Br. 1970 May;52(2):205-26 [5445403.001]
  • [Cites] AJR Am J Roentgenol. 1976 Oct;127(4):686-8 [970548.001]
  • [Cites] Hum Pathol. 1993 Sep;24(9):944-9 [8253461.001]
  • [Cites] Skeletal Radiol. 1995 Apr;24(3):220-2 [7610417.001]
  • [Cites] Pediatr Pathol Mol Med. 2002 Jan-Feb;21(1):71-4 [11842980.001]
  • [Cites] Cancer. 1972 Aug;30(2):401-13 [5051664.001]
  • [Cites] Hum Pathol. 1989 Oct;20(10 ):965-76 [2793161.001]
  • [Cites] Am J Pathol. 1942 Nov;18(6):969-91 [19970672.001]
  • [Cites] Skeletal Radiol. 2000 Mar;29(3):176-80 [10794557.001]
  • [Cites] J Postgrad Med. 1980 Oct;26(4):259-60 [7230063.001]
  • [Cites] Cancer. 1964 May;17:578-89 [14159807.001]
  • [Cites] Clin Orthop Relat Res. 2006 Sep;450:12-6 [16951639.001]
  • [Cites] Cancer. 1972 Jun;29(6):1546-62 [4260603.001]
  • (PMID = 16010594.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


20. Matsuo T, Hiyama E, Sugita T, Shimose S, Kubo T, Mochizuki Y, Adachi N, Kojima K, Sharman P, Ochi M: Telomerase activity in giant cell tumors of bone. Ann Surg Oncol; 2007 Oct;14(10):2896-902
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Telomerase activity in giant cell tumors of bone.
  • BACKGROUND: A giant cell tumor of bone (GCT) is a histologically benign neoplasma that has an unpredictable pattern of biological aggressiveness.
  • The telomere lengths of tumors were significantly shorter than those of normal tissue (P = .008).
  • The mean telomere length of grade 3 tumors was significantly shorter than those of grade 1 and 2 tumors (P = .038).
  • Telomerase activity was detected in 81% of tumor samples.
  • The level of telomerase activity in tumors with local recurrence was significantly higher than in tumors without local recurrence (P = .011).
  • [MeSH-major] Bone Neoplasms / genetics. Giant Cell Tumor of Bone / genetics. Telomerase / genetics
  • [MeSH-minor] Adolescent. Adult. Blotting, Southern. Bone and Bones / pathology. Bone and Bones / surgery. Extremities / surgery. Female. Femoral Neoplasms / genetics. Femoral Neoplasms / pathology. Femoral Neoplasms / surgery. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / genetics. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Neoplasm Staging. Polymerase Chain Reaction. Polymorphism, Restriction Fragment Length / genetics. Prognosis

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17653593.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.7.49 / TERT protein, human; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


21. Prasad K, Rao SG, Harish K: Giant cell tumor of the temporal bone--a case report. BMC Ear Nose Throat Disord; 2005 Sep 15;5:8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant cell tumor of the temporal bone--a case report.
  • BACKGROUND: Giant cell tumor is a benign but locally aggressive bone neoplasm which uncommonly involves the skull.
  • The petrous portion of the temporal bone forms a rare location for this tumor.
  • CASE PRESENTATION: The authors report a case of a large giant cell tumor involving the petrous and squamous portions of the temporal bone in a 26 year old male patient.
  • Radical excision of the tumor was achieved but facial palsy could not be avoided.
  • CONCLUSION: Radical excision of skull base giant cell tumor may be hazardous but if achieved is the optimal treatment and may be curative.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Maxillofac Surg. 2004 Jan;62(1):116-8 [14733232.001]
  • [Cites] Skeletal Radiol. 2005 Apr;34(4):225-8 [15365782.001]
  • [Cites] J Lab Clin Med. 2004 Oct;144(4):193-200 [15514587.001]
  • [Cites] J Orthop Res. 2005 Jan;23(1):203-9 [15607894.001]
  • [Cites] J Neurosurg. 1983 Aug;59(2):322-7 [6864300.001]
  • [Cites] J Orthop Res. 2000 Jul;18(4):647-54 [11052502.001]
  • [Cites] Neuroradiology. 1999 Apr;41(4):305-7 [10344520.001]
  • [Cites] Int J Oncol. 1999 Feb;14(2):291-300 [9917505.001]
  • [Cites] Histopathology. 1979 Nov;3(6):511-22 [511122.001]
  • [Cites] Surg Neurol. 1985 Jan;23(1):25-30 [3964973.001]
  • [Cites] J Oral Pathol Med. 1999 Feb;28(2):54-8 [9950250.001]
  • [Cites] J Neurosurg. 1994 Jan;80(1):148-51 [8271002.001]
  • [Cites] J Neurosurg. 1987 Jun;66(6):924-8 [3572521.001]
  • [Cites] Cancer. 1992 Sep 1;70(5):1124-32 [1515987.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1988 Aug;66(2):197-208 [3174054.001]
  • [Cites] Surg Neurol. 1978 Mar;9(3):185-8 [635765.001]
  • [Cites] Am J Pathol. 2005 Jul;167(1):117-28 [15972958.001]
  • [Cites] Indian J Cancer. 1991 Dec;28(4):177-80 [1818017.001]
  • [Cites] Surg Neurol. 1986 Jul;26(1):59-62 [3715701.001]
  • [Cites] Clin Orthop Relat Res. 2005 Jun;(435):211-8 [15930941.001]
  • [Cites] Neurosurgery. 1988 Jul;23 (1):120-2 [3173651.001]
  • [Cites] Am J Clin Pathol. 2002 Feb;117(2):210-6 [11863217.001]
  • (PMID = 16162299.001).
  • [ISSN] 1472-6815
  • [Journal-full-title] BMC ear, nose, and throat disorders
  • [ISO-abbreviation] BMC Ear Nose Throat Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1253509
  •  go-up   go-down


22. Weber KL, Peabody T, Frassica FJ, Mott MP, Parsons TW 3rd: Tumors for the general orthopedist: how to save your patients and practice. Instr Course Lect; 2010;59:579-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumors for the general orthopedist: how to save your patients and practice.
  • It is likely that most orthopaedic surgeons will see a patient with a benign or malignant musculoskeletal tumor sometime during their career.
  • However, because of the rarity of these entities, many surgeons may benefit from a review of how to evaluate a patient with a bone lesion or soft-tissue mass.
  • A logical approach is necessary in evaluating imaging studies as well as in the workup of children and adults with a possible tumor.
  • If the treatment algorithms lead to a conclusive diagnosis of a benign bone tumor, benign soft-tissue mass, or metastatic bone disease, the orthopaedic surgeon may choose to definitively treat the patient.
  • [MeSH-major] Bone Neoplasms / diagnosis. Bone Neoplasms / surgery. Cysts / diagnosis. Joint Diseases / pathology. Orthopedics. Soft Tissue Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Joint Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20415407.001).
  • [ISSN] 0065-6895
  • [Journal-full-title] Instructional course lectures
  • [ISO-abbreviation] Instr Course Lect
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


23. Malek F, Krueger P, Hatmi ZN, Malayeri AA, Faezipour H, O'Donnell RJ: Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy. Int Orthop; 2006 Dec;30(6):495-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy.
  • Giant cell tumour (GCT) is a benign, but aggressive, primary tumour of the bone.
  • Many surgical techniques have been employed in the treatment of this tumour.
  • In addition to curettage, various adjuvant procedures and packing materials have been advocated in order to control and reconstruct long bone defects secondary to this neoplasm.
  • We report our experience with 40 long bone GCT patients treated with curettage, burring, bone grafting and no adjuvants between 1997 and 2002.
  • The risk of local recurrence in this study is acceptable (within the range that has been historically reported for curettage and bone grafting).
  • [MeSH-major] Bone Neoplasms / surgery. Bone Transplantation / methods. Giant Cell Tumor of Bone / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Cohort Studies. Developing Countries. Female. Humans. Iran. Kaplan-Meier Estimate. Male. Middle Aged. Neoplasm Recurrence, Local / prevention & control. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 2002 Apr;(397):259-70 [11953617.001]
  • [Cites] Clin Orthop Relat Res. 2002 Apr;(397):248-58 [11953616.001]
  • [Cites] J Bone Joint Surg Am. 1970 Jun;52(4):619-64 [5479455.001]
  • [Cites] Recent Results Cancer Res. 1976;(54):257-61 [1013500.001]
  • [Cites] J Bone Joint Surg Am. 1980;62(4):652-6 [7380862.001]
  • [Cites] J Bone Joint Surg Am. 1982 Jun;64(5):755-61 [7045129.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):9-24 [3456859.001]
  • [Cites] J Bone Joint Surg Am. 1987 Jan;69(1):106-14 [3805057.001]
  • [Cites] Chir Organi Mov. 1990;75(1 Suppl):206 [2249534.001]
  • [Cites] J Bone Joint Surg Am. 1993 Nov;75(11):1648-55 [8245057.001]
  • [Cites] J Bone Joint Surg Am. 1994 Dec;76(12):1827-33 [7989388.001]
  • [Cites] Clin Orthop Relat Res. 1995 Dec;(321):245-50 [7497676.001]
  • [Cites] Bull Hosp Jt Dis. 1998;57(1):6-10 [9553696.001]
  • [Cites] Pathol Int. 1998 Sep;48(9):723-9 [9778111.001]
  • [Cites] J Bone Joint Surg Am. 1999 Jun;81(6):811-20 [10391546.001]
  • [Cites] Bull Hosp Jt Dis. 1999;58(2):98-104 [10509202.001]
  • [Cites] Clin Orthop Relat Res. 2005 Jun;(435):211-8 [15930941.001]
  • [Cites] Clin Orthop Relat Res. 2005 Oct;439:144-50 [16205153.001]
  • [Cites] Clin Orthop Relat Res. 2002 Jul;(400):201-10 [12072763.001]
  • (PMID = 16896875.001).
  • [ISSN] 0341-2695
  • [Journal-full-title] International orthopaedics
  • [ISO-abbreviation] Int Orthop
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Other-IDs] NLM/ PMC3172751
  •  go-up   go-down


24. Simonetti S, Mignogna C, La Mantia V, Lanza F, Insabato L: Primary intraosseous cavernous hemangioma of the metacarpal bone: a very rare entity. Case report. Tumori; 2009 Jan-Feb;95(1):101-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intraosseous cavernous hemangioma of the metacarpal bone: a very rare entity. Case report.
  • Intraosseous cavernomas are very rare benign lesions representing less than 1% of all skeletal tumors and most frequently observed in vertebrae and head and neck bones.
  • We report a case of this neoplasm in the distal epiphysis of the third metacarpal bone in a 68-year-old man, along with the clinicopathological findings.
  • The differential diagnosis and a review of the literature are discussed.
  • [MeSH-major] Bone Neoplasms / pathology. Hemangioma, Cavernous / pathology. Metacarpal Bones / pathology

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19366066.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Cueva del Castillo JF, Francisco Osuna J, Elizondo F, Pérez O, Pérez A, Hernández S, Mejía C: [Use of a xenoimplant for the treatment of bone defects, benign tumors, pseudoarthrosis and arthrodesis. Preliminary report]. Acta Ortop Mex; 2007 Jan-Feb;21(1):31-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Use of a xenoimplant for the treatment of bone defects, benign tumors, pseudoarthrosis and arthrodesis. Preliminary report].
  • [Transliterated title] Aplicación de xenoimplante para el tratamiento de defectos oseos, tumores benignos, seudoartrosis y artrodesis. (Reporte preliminar).
  • OBJECTIVE: To show that the ceramic produced at the Institute for Materials Research, National Autonomous University of Mexico, is an appropriate replacement of bone graft in patients with bone tumors, benign tumors, pseudoarthrosis and arthrodesis treated at "General Ignacio Zaragoza" Regional Hospital.
  • They underwent X-ray evaluation of bone healing using the Montoya classification.
  • The most frequent indication was arthrodesis in 10 patients (45.45%), pseudoarthrosis in 6 (27.27%), benign tumors in 3 (13.63%), and bone defects in 3 (13.63%).
  • Type II to type IV bone healing was observed in the sample.
  • DISCUSSION: The use of ceramic xenoimplants is appropriate as a replacement of bone graft in patients with arthrodesis and bone defects, thus avoiding the need for autologous bone graft.
  • [MeSH-major] Arthrodesis. Bone Neoplasms / surgery. Bone Transplantation. Pseudarthrosis / surgery. Transplantation, Heterologous

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17695206.001).
  • [ISSN] 2306-4102
  • [Journal-full-title] Acta ortopédica mexicana
  • [ISO-abbreviation] Acta Ortop Mex
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


26. Miyake A, Morioka H, Yabe H, Anazawa U, Morii T, Miura K, Mukai M, Takayama S, Toyama Y: A case of metacarpal chondrosarcoma of the thumb. Arch Orthop Trauma Surg; 2006 Aug;126(6):406-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Enchondroma is the most common primary benign bone tumor of the hand.
  • It often is difficult to make a histological distinction between benign cartilaginous tumors and low-grade chondrosarcomas, because enchondromas at this site often show histological features suggestive of malignancy.
  • This is a case report of chondrosarcoma affecting the metacarcal bone of the thumb, treated by en block resection and preserving the function of the thumb by bone graft reconstruction, with reference to the literature.
  • [MeSH-major] Bone Neoplasms / surgery. Chondrosarcoma / surgery. Metacarpal Bones

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16557368.001).
  • [ISSN] 0936-8051
  • [Journal-full-title] Archives of orthopaedic and trauma surgery
  • [ISO-abbreviation] Arch Orthop Trauma Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


27. Atalar B, Miller RC, Dincbas FO, Geismar JH, Micke O, Akyurek S, Ozyar E: Adult langerhans cell histiocytosis of bones : a rare cancer network study. Acta Orthop Belg; 2010 Oct;76(5):663-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Langerhans Cell Histiocytosis (LCH) is an uncommon benign bone tumour typically seen in children.
  • The localization of tumours was skull bones in 12 (40%), lower extremity in 6 (20%), thoracic bones in 4 (133%), spine in 3 (10%), pelvis in 2 (6.7%) and multiple sites in 3 (10%) patients.
  • [MeSH-major] Bone Diseases / therapy. Histiocytosis, Langerhans-Cell / therapy


28. Liu H, Sun J, Wang Y, Yang X, Zhu E: [Repairing bone defects of benign bone neoplasm by grafting of bioactive glass combined with autologous bone marrow]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Nov;22(11):1349-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Repairing bone defects of benign bone neoplasm by grafting of bioactive glass combined with autologous bone marrow].
  • OBJECTIVE: To investigate the clinical application of grafting with bioactive glass (BG) and autologous bone marrow for defect after resection and curettage of benign bone neoplasm.
  • METHODS: From January 2004 to May 2007, 34 patients with bone defects were repaired.
  • There were 14 cases of simple bone cysts, 6 cases of fibrous dysplasia, 3 cases of osteoid osteoma, 4 cases of non-ossifying fibroma, 2 cases of enchondroma and 3 cases of giant cell tumor of bone.
  • Tumor sizes varied from 2.0 cm x 1.5 cm x 1.0 cm to 9.0 cm x 3.0 cm x 2.5 cm.
  • Benign bone neoplasm was removed thoroughly with a curet or osteotome, bone defects ranged from 3.0 cm x 2.0 cm x 1.5 cm to 11.0 cm x 3.5 cm x 3.0 cm, which was closed-up with the mixtures of BG and autogenous red bone marrow.
  • The postoperative systemic and local reactions were observed, and the regular X-ray examinations were performed to observe the bone healing.
  • At averaged 16 weeks after operation, patients with bone tumor in lower limbs resumed walking independently and those with bone tumor in upper limbs resumed holding object.
  • There was no tumor recurrence during follow-up.
  • Radiographically, the interface between the implanted bone and host bone became fuzzy 1 month after implantation.
  • Two months after operation, the BG was absorbed gradually, new bone formation could be seen in the defects.
  • Four months after operation, implanted bone and host bone merged together, bone density increased.
  • Six to ten months after operation, the majority of the implanted BG was absorbed and substituted for new bone, bone remodeling was established.
  • CONCLUSION: BG may boast both bone conductive and bone inductive activities.
  • The combined grafting with BG and autologous bone marrow appears to be minimally invasive treatment to repair bone defects of benign bone neoplasm, with rare complications and no significant reverse reaction, and could repair bone defects completely.
  • [MeSH-major] Bone Marrow Transplantation. Bone Substitutes. Postoperative Complications / surgery. Reconstructive Surgical Procedures / methods
  • [MeSH-minor] Adolescent. Adult. Bone Neoplasms / surgery. Bone and Bones / pathology. Child. Female. Follow-Up Studies. Glass. Humans. Male. Middle Aged. Transplantation, Autologous

  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Bone Marrow Transplantation.
  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19068605.001).
  • [ISSN] 1002-1892
  • [Journal-full-title] Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
  • [ISO-abbreviation] Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Bone Substitutes
  •  go-up   go-down


29. Yilmaz MH, Ozguroglu M, Mert D, Turna H, Demir G, Adaletli I, Ulus S, Halac M, Kanberoğlu K: Diagnostic value of magnetic resonance imaging and scintigraphy in patients with metastatic breast cancer of the axial skeleton: a comparative study. Med Oncol; 2008;25(3):257-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: The goal of this study was to compare the sensitivity of MRI and scintigraphy for detecting metastatic bone disease involving the axial skeleton.
  • All the patients underwent scintigraphy and MRI examinations for staging, follow-up, or evaluation of bone pain.
  • Four lesions detected by MRI were classified as of uncertain origin (grade 2) and 36 lesions were regarded as definitely benign (grade 1).
  • A total of 29 lesions were considered as of uncertain origin (grade 2), and 26 lesions were regarded as definitely benign (grade 1).
  • About five lesions were graded as grade 2 in scintigraphy, while MRI graded them as degeneration or benign compression (Grade 1).
  • CONCLUSION: MRI is more sensitive than scintigraphy in the detection of bone metastases.
  • [MeSH-major] Bone Neoplasms / secondary. Breast Neoplasms / pathology. Magnetic Resonance Imaging
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diphosphonates. Female. Humans. Male. Middle Aged. Neoplasm Staging. Organotechnetium Compounds. Predictive Value of Tests. Radiography. Radionuclide Imaging. Sensitivity and Specificity. Whole Body Imaging

  • Genetic Alliance. consumer health - Breast Cancer.
  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comput Assist Tomogr. 1989 Jul-Aug;13(4):598-602 [2745777.001]
  • [Cites] CA Cancer J Clin. 1999 Jan-Feb;49(1):8-31, 1 [10200775.001]
  • [Cites] Radiology. 1993 Jul;188(1):249-52 [8511306.001]
  • [Cites] Skeletal Radiol. 1986;15(1):1-9 [3941915.001]
  • [Cites] AJR Am J Roentgenol. 1986 Feb;146(2):353-8 [3484586.001]
  • [Cites] Cancer. 1997 Oct 15;80(8 Suppl):1595-607 [9362427.001]
  • [Cites] Radiol Clin North Am. 1987 Nov;25(6):1155-70 [3671711.001]
  • [Cites] Clin Orthop Relat Res. 1982 Sep;(169):38-43 [6179682.001]
  • [Cites] Clin Nucl Med. 1989 Oct;14 (10 ):742-9 [2805524.001]
  • [Cites] Blood. 1991 Aug 1;78(3):728-38 [1859885.001]
  • [Cites] Cancer. 1987 Nov 15;60(10 ):2524-31 [3664434.001]
  • [Cites] Clin Orthop Relat Res. 1986 Sep;(210):18-30 [3757360.001]
  • [Cites] AJR Am J Roentgenol. 1990 Nov;155(5):1043-8 [2120933.001]
  • [Cites] Clin Radiol. 1976 Jan;27(1):9-15 [177243.001]
  • [Cites] Semin Nucl Med. 1995 Apr;25(2):76-91 [7597422.001]
  • [Cites] Skeletal Radiol. 1990;19(2):113-6 [2321040.001]
  • [Cites] Spine (Phila Pa 1976). 1996 Oct 1;21(19):2243-50 [8902969.001]
  • [Cites] Magn Reson Imaging. 1994;12 (6):829-35 [7968282.001]
  • [Cites] Eur J Radiol. 2001 Oct;40(1):16-23 [11673003.001]
  • [Cites] Eur J Cancer Clin Oncol. 1982 Jul;18(7):629-36 [6889965.001]
  • [Cites] Magn Reson Imaging. 1991;9(3):349-55 [1881253.001]
  • [Cites] J Clin Oncol. 1994 Jul;12(7):1415-21 [8021732.001]
  • [Cites] Nucl Med Commun. 1992 Jun;13(6):429-31 [1407869.001]
  • [Cites] Cancer. 1986 Jul 1;58(1):178-82 [2423224.001]
  • [Cites] AJR Am J Roentgenol. 1997 Dec;169(6):1655-61 [9393186.001]
  • [Cites] Am J Med. 1986 Sep;81(3):381-6 [2428242.001]
  • [Cites] J Comput Assist Tomogr. 1989 Jul-Aug;13(4):717-9 [2745798.001]
  • [Cites] Radiology. 1989 Jul;172(1):215-8 [2740506.001]
  • [Cites] Eur Radiol. 2004 Dec;14 (12 ):2297-302 [15243716.001]
  • [Cites] Radiol Clin North Am. 1990 Mar;28(2):471-83 [2408106.001]
  • [Cites] Magn Reson Imaging. 1992;10(2):169-76 [1564986.001]
  • [Cites] Semin Oncol. 1991 Apr;18(2):158-69 [2014400.001]
  • [Cites] Eur J Nucl Med. 1993 Nov;20(11):1063-9 [8287874.001]
  • [Cites] J Comput Assist Tomogr. 1999 Jan-Feb;23 (1):123-9 [10050822.001]
  • [Cites] Br J Cancer. 1973 Apr;27(4):336-40 [4701705.001]
  • [Cites] Lancet. 1983 Sep 10;2(8350):613-6 [6136757.001]
  • [Cites] Br J Urol. 1995 Jan;75(1):54-8 [7850297.001]
  • [Cites] AJR Am J Roentgenol. 1977 Dec;129(6):1095-6 [74204.001]
  • [Cites] J Nucl Med. 1996 Jun;37(6):975-8 [8683325.001]
  • [Cites] J Nucl Med. 1993 Dec;34(12 ):2191-8 [8254410.001]
  • (PMID = 18040900.001).
  • [ISSN] 1357-0560
  • [Journal-full-title] Medical oncology (Northwood, London, England)
  • [ISO-abbreviation] Med. Oncol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Diphosphonates; 0 / Organotechnetium Compounds; 0 / technetium 99m methylene bisphosphonate
  •  go-up   go-down


30. Sohn SH, Koh SA, Kim DG, Park SW, Lee KH, Kim MK, Choi JH, Hyun MS: A case of spine origin chondroblastoma metastasis to lung. Cancer Res Treat; 2009 Dec;41(4):241-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chondroblastoma is a rare benign cartilaginous neoplasm that accounts for approximately 1% of all bone tumors and characteristically arises in the epiphysis of a long bone, particularly the humerus, tibia, and femur.
  • Unlike previously published examples of metastatic chondroblastoma, these metastasis developed before any operative manipulation of the primary tumor.
  • And primary tumor site was also unusual.
  • The histologic characteristics of the primary, metastatic tumors were those of a conventional chondroblastoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Br. 1957 Nov;39-B(4):705-10 [13491633.001]
  • [Cites] J Comput Assist Tomogr. 1999 Sep-Oct;23(5):721-6 [10524855.001]
  • [Cites] Cancer. 1998 Feb 15;82(4):675-8 [9477099.001]
  • [Cites] Skeletal Radiol. 1995 Apr;24(3):220-2 [7610417.001]
  • [Cites] Hum Pathol. 1989 Oct;20(10):965-76 [2793161.001]
  • [Cites] J Pathol. 1999 Dec;189(4):463-9 [10629544.001]
  • [Cites] Am J Clin Pathol. 1987 Jul;88(1):1-9 [3604981.001]
  • [Cites] Pathol Res Pract. 1987 Feb;182(1):113-23 [3588400.001]
  • [Cites] Acta Orthop Scand. 1986 Aug;57(4):378-81 [3788507.001]
  • [Cites] Cancer. 1985 Apr 15;55(8):1770-89 [3978565.001]
  • [Cites] Clin Orthop Relat Res. 1977 Jul-Aug;(126):266-72 [598130.001]
  • [Cites] Pediatr Radiol. 1987;17(5):392-6 [3627860.001]
  • (PMID = 20057972.001).
  • [ISSN] 2005-9256
  • [Journal-full-title] Cancer research and treatment : official journal of Korean Cancer Association
  • [ISO-abbreviation] Cancer Res Treat
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2802843
  • [Keywords] NOTNLM ; Chondroblastoma / Lung metastasis / Spine origin
  •  go-up   go-down


31. Kumar A, Varshney MK, Trikha V, Rastogi S: An unusual presentation of a rare chest wall tumour: giant cell tumour of bone. Joint Bone Spine; 2007 Jan;74(1):100-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual presentation of a rare chest wall tumour: giant cell tumour of bone.
  • Giant cell tumour of bone is an aggressive benign bone tumour.
  • We report a case of giant cell tumour of the anterior end of the rib masquerading as a sub-mammary abscess in lactating women.
  • [MeSH-major] Bone Neoplasms / diagnosis. Giant Cell Tumor of Bone / diagnosis. Thoracic Wall
  • [MeSH-minor] Abscess / diagnosis. Adult. Diagnosis, Differential. Female. Humans. Lactation. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17197221.001).
  • [ISSN] 1778-7254
  • [Journal-full-title] Joint, bone, spine : revue du rhumatisme
  • [ISO-abbreviation] Joint Bone Spine
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


32. Arpino L, Gragnaniello C, Nina P, Franco A: Limited approach to a thoracic spine osteoblastoma. J Neurosurg Sci; 2008 Dec;52(4):123-5; discussion 125
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoblastoma (OB) is a rare primary benign bone tumor.
  • The peak incidence of this neoplasm is in the first two decades of life.
  • It is important to differentiate OB from osteoid osteoma, a very similar bone tumor.
  • OB is rare benign bone neoplasm that generally affect the posterior elements of the spine.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18981987.001).
  • [ISSN] 0390-5616
  • [Journal-full-title] Journal of neurosurgical sciences
  • [ISO-abbreviation] J Neurosurg Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


33. Veth R, Schreuder B, van Beem H, Pruszczynski M, de Rooy J: Cryosurgery in aggressive, benign, and low-grade malignant bone tumours. Lancet Oncol; 2005 Jan;6(1):25-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cryosurgery in aggressive, benign, and low-grade malignant bone tumours.
  • Cryosurgery is a method of treatment for various tumours that induces tissue necrosis with ablative intent.
  • It is used in benign, aggressive, and low-grade malignant bone tumours such as chondrosarcoma grade 1.
  • At the University Medical Centre Nijmegen, Netherlands, 302 tumours have been treated by use of cryosurgery with at least 2 years' follow-up.
  • 96-100% of patients were cured-the response depended on tumour type.
  • [MeSH-major] Bone Neoplasms / surgery. Chondrosarcoma / surgery. Cryosurgery / methods
  • [MeSH-minor] Humans. Neoplasm Staging. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15629273.001).
  • [ISSN] 1470-2045
  • [Journal-full-title] The Lancet. Oncology
  • [ISO-abbreviation] Lancet Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 76
  •  go-up   go-down


34. Röpke M, Boltze C, Meyer B, Neumann HW, Roessner A, Schneider-Stock R: Rb-loss is associated with high malignancy in chondrosarcoma. Oncol Rep; 2006 Jan;15(1):89-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We studied the loss of heterozygosity (LOH) of the Rb gene in 31 formalin-fixed, paraffin-embedded cartilaginous tumors using polymerase chain reaction.
  • The tumors were subdivided into 8 cases of dedifferentiated (DD) chondrosarcoma, 17 cases of conventional chondrosarcoma (nine grade 1, seven grade 2 and one grade 3), 4 enchondromas and 2 chondroblastomas.
  • All tumors with Rb-LOH were immunohistochemically Rb-negative.
  • The only case of DD chondrosarcoma negative for Rb-LOH in both components of the tumor also showed weak expression of the Rb protein in the anaplastic component.
  • All benign cartilaginous tumors, low-grade chondrosarcomas and low-grade tumor components of DD chondrosarcomas were negative regarding Rb-LOH but positive in Rb immunohistostaining.
  • However, it is not a marker for identifying low-grade tumors with a tendency towards progression or local recurrence.
  • [MeSH-major] Bone Neoplasms / diagnosis. Chondrosarcoma / diagnosis. Genes, Retinoblastoma / genetics. Loss of Heterozygosity / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Child. DNA, Neoplasm / analysis. Female. Humans. Immunohistochemistry. Male. Middle Aged. Polymerase Chain Reaction. Prognosis. Retinoblastoma Protein / analysis. Retinoblastoma Protein / genetics


35. Zhang Q, Zhao H, Maheshwari AV, Cai L, Yu F, Niu X: Isolated cardiac metastasis from a histologically "benign" giant-cell tumor of the distal end of the femur: a case report. J Bone Joint Surg Am; 2010 Nov 17;92(16):2725-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Isolated cardiac metastasis from a histologically "benign" giant-cell tumor of the distal end of the femur: a case report.
  • [MeSH-major] Bone Neoplasms / pathology. Femur / pathology. Giant Cell Tumor of Bone / secondary. Heart Neoplasms / secondary
  • [MeSH-minor] Adult. Biopsy, Needle. Disease Progression. Fatal Outcome. Heart Failure / diagnosis. Humans. Immunohistochemistry. Male. Neoplasm Staging. Orthopedic Procedures / methods. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21084583.001).
  • [ISSN] 1535-1386
  • [Journal-full-title] The Journal of bone and joint surgery. American volume
  • [ISO-abbreviation] J Bone Joint Surg Am
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


36. Conway EJ, Wen J, Feng Y, Mo A, Huang WT, Keever-Taylor CA, Hari P, Vesole DH, Chang CC: Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry. Arch Pathol Lab Med; 2009 Oct;133(10):1594-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These cells have been postulated to act as a therapy-resistant tumor reservoir that drives recurrence.
  • However, the same or similar immunophenotyping can be detected in both clonotypic B lymphocytes and benign progenitor B cells, suggesting clonality analysis might be needed to determine clonotypic B lymphocytes in patients with myeloma.
  • [MeSH-minor] Adult. Aged. Bone Marrow / pathology. Bone Marrow Transplantation. Clone Cells / immunology. DNA, Neoplasm / genetics. Female. Gene Rearrangement, B-Lymphocyte, Heavy Chain. Hematopoietic Stem Cell Mobilization. Hematopoietic Stem Cells. Humans. Immunoglobulin Light Chains / blood. Male. Middle Aged. Neoplasm Staging. Plasma Cells / immunology. Plasma Cells / pathology. Remission Induction

  • Genetic Alliance. consumer health - Multiple myeloma.
  • MedlinePlus Health Information. consumer health - Multiple Myeloma.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19792049.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA096952
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Immunoglobulin Light Chains
  •  go-up   go-down


37. Chen YR, Chang CN, Tan YC: Craniofacial fibrous dysplasia: an update. Chang Gung Med J; 2006 Nov-Dec;29(6):543-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fibrous dysplasia was first described by Lichtenstein in 1938 as a disorder characterized by progressive replacement of normal bone elements by fibrous tissue.
  • It is a bone tumor that, although benign, has the potential to cause significant cosmetic and functional disturbance, particularly in the craniofacial skeleton.

  • Genetic Alliance. consumer health - Fibrous Dysplasia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17302216.001).
  • [ISSN] 2072-0939
  • [Journal-full-title] Chang Gung medical journal
  • [ISO-abbreviation] Chang Gung Med J
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] China (Republic : 1949- )
  • [Number-of-references] 50
  •  go-up   go-down


38. Mukonoweshuro P, Oriowolo A: Stromal osseous metaplasia in a low-grade ovarian adenocarcinoma. Gynecol Oncol; 2005 Oct;99(1):222-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Stromal osseous metaplasia in a low-grade ovarian adenocarcinoma.
  • BACKGROUND: Stromal osseous metaplasia is a rare and curious finding in tumors of the ovary.
  • The tumor recurred 21 years later with prominent stromal osseous metaplasia that had not been present in the primary.
  • DISCUSSION: The pathogenesis of osseous metaplasia in epithelial tumors of the ovary is unclear; however, it is probable that a metaplastic process involving multipotential stromal stem cells results in bone formation.
  • CONCLUSION: Benign osseous metaplasia in ovarian tumors is rare and its histogenesis remains unclear.
  • [MeSH-major] Carcinoma, Endometrioid / pathology. Neoplasm Recurrence, Local / pathology. Ovarian Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16023183.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


39. Fisher CG, Keynan O, Boyd MC, Dvorak MF: The surgical management of primary tumorsof the spine: initial results of an ongoing prospective cohort study. Spine (Phila Pa 1976); 2005 Aug 15;30(16):1899-908
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To prospectively validate the application of appendicular surgical oncology principles to the treatment of primary bone tumors of the spine at a quaternary care spine center using local recurrence, survival, and health-related quality of life as outcome measures.
  • Previous publications have retrospectively demonstrated this oncologically sound approach to spine tumor management to be internally valid.
  • METHODS: Included were all patients who underwent en bloc surgical resection of a primary tumor of the spine between January 1994 and November 2003, at the authors' institution.
  • There were 19 malignant tumors and 7 benign.
  • There are 20 surviving patients with an average follow-up of 41.5 months (range 6 to 111 months), 15 of whom had malignant tumors.
  • CONCLUSIONS: Principles of wide surgical resection, commonly applied in appendicular oncology, can and should be used for the treatment of primary bone tumors of the spine with anticipated acceptable morbidity and satisfactory survival.
  • [MeSH-minor] Adolescent. Adult. Aged. Cohort Studies. Female. Health Status. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Prospective Studies. Quality of Life. Survival Analysis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16103863.001).
  • [ISSN] 1528-1159
  • [Journal-full-title] Spine
  • [ISO-abbreviation] Spine
  • [Language] eng
  • [Publication-type] Journal Article; Validation Studies
  • [Publication-country] United States
  •  go-up   go-down


40. Prado MP, Mendes AA, Amodio DT: Benign bone tumors subperiosteal on the talar neck resected anthroscopically: case reports. Einstein (Sao Paulo); 2010 Sep;8(3):354-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign bone tumors subperiosteal on the talar neck resected anthroscopically: case reports.
  • Two cases of benign chondral tumors of the talar neck region (an osteoid osteoma and a chondroblastoma) were described.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 26760154.001).
  • [ISSN] 1679-4508
  • [Journal-full-title] Einstein (São Paulo, Brazil)
  • [ISO-abbreviation] Einstein (Sao Paulo)
  • [Language] eng; por
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


41. Kitsoulis P, Galani V, Stefanaki K, Paraskevas G, Karatzias G, Agnantis NJ, Bai M: Osteochondromas: review of the clinical, radiological and pathological features. In Vivo; 2008 Sep-Oct;22(5):633-46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteochondroma is the most common benign bone tumor and usually occurs in the metaphyseal region of the long bones.
  • This tumor takes the form of a cartilage-capped bony outgrowth on the surface of the bone.
  • Approximately 15% of osteochondromas occur as multiple lesions in the context of hereditary multiple osteochondromas (HMOs), a disorder that is inherited in an autosomal dominant manner.
  • [MeSH-major] Bone Neoplasms / pathology. Bone Neoplasms / radiography. Osteochondroma / pathology. Osteochondroma / radiography

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18853760.001).
  • [ISSN] 0258-851X
  • [Journal-full-title] In vivo (Athens, Greece)
  • [ISO-abbreviation] In Vivo
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Greece
  • [Chemical-registry-number] EC 2.4.1.- / N-Acetylglucosaminyltransferases; EC 2.4.1.224 / exostosin-1; EC 2.4.1.224 / exostosin-2
  • [Number-of-references] 125
  •  go-up   go-down


42. Tanigawa N, Kariya S, Kojima H, Komemushi A, Fujii H, Sawada S: Lower limb ischaemia caused by fractured osteochondroma of the femur. Br J Radiol; 2007 Apr;80(952):e78-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteochondroma is the most common benign bone tumour and can arise in any bone.
  • [MeSH-major] Bone Neoplasms / complications. Exostoses, Multiple Hereditary / complications. Femoral Fractures / complications. Ischemia / etiology. Leg / blood supply


43. Harimaya A, Tsubota H, Hoki K, Sato J, Kondo A, Yamada T, Seki N, Ikeda H, Himi T: Ossifying fibroma of the mandible with primary hyperparathyroidism due to non-familial parathyroid adenoma. J Laryngol Otol; 2007 Mar;121(3):281-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ossifying fibroma is an uncommon benign osteogenic neoplasm arising from cells of the periodontal ligament, typically with a slowly progressive enlargement of the affected bone.
  • The neoplasm sometimes presents with hyperparathyroidism, most of which cases are due to familial parathyroid tumours.
  • Despite improvement of parathyroid dysfunction after removal of the parathyroid adenoma, the tumour continued to grow very aggressively.
  • The case required partial mandibular resection for complete resection of the tumour, and fixation of the remaining mandible with a titanium plate.
  • [MeSH-major] Adenoma / diagnosis. Fibroma, Ossifying / diagnosis. Hyperparathyroidism, Primary / etiology. Mandibular Neoplasms / diagnosis. Parathyroid Neoplasms / diagnosis
  • [MeSH-minor] Adult. Humans. Male. Neoplasms, Multiple Primary / diagnosis


44. Li J, Wang ZQ, Zhang YM, Song HP, Yuan L: [Application of allogeneic bone in surgical treatment of benign bone neoplasm]. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul;26(7):987-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Application of allogeneic bone in surgical treatment of benign bone neoplasm].
  • OBJECTIVE: To evaluate the clinical outcomes of allogeneic bone grafting for bone defect resulting from benign neoplasm resection and discuss the clinical application and bone defect repair mechanisms of allogeneic bone.
  • METHODS: A retrospective review was conducted of 135 patients with benign neoplasm resection who received bone defect filling with the allogeneic bone graft.
  • RESULTS: In the 104 patients with complete clinical follow-up data, 96 achieved bone union, 7 experienced relapses to require surgical intervention and 1 had severe infection to lead to failure of the operation.
  • The mean time for bone union was 9.7 months, and during the follow-up, no viral disease in relation to the graft was found after surgery.
  • CONCLUSION: Bone defect filling with allogeneic bone graft can be simple and safe in comparison with that with autograft or other biomaterials, and the bone healing time, infection rate and local tumor recurrence can be comparable with the autograft.
  • [MeSH-major] Bone Neoplasms / surgery. Bone Transplantation / methods

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16864094.001).
  • [ISSN] 1673-4254
  • [Journal-full-title] Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • [ISO-abbreviation] Nan Fang Yi Ke Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


45. Schmidt GP, Schoenberg SO, Reiser MF, Baur-Melnyk A: Whole-body MR imaging of bone marrow. Eur J Radiol; 2005 Jul;55(1):33-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Whole-body MR imaging of bone marrow.
  • In clinical routine, multimodality algorithms, including X-ray, computed tomography, scintigraphy and MRI, are used in case of suspected bone marrow malignancy.
  • Skeletal scintigraphy is widely used to asses metastatic disease to the bone, CT is the technique of choice to assess criteria of osseous destruction and bone stability.
  • MRI is the only imaging technique that allows direct visualization of bone marrow and its components with high spatial resolution.
  • The combination of unenhanced T1-weighted-spin echo- and turbo-STIR-sequences have shown to be most useful for the detection of bone marrow abnormalities and are able to discriminate benign from malignant bone marrow changes.
  • Originally, whole-body MRI bone marrow screening was performed in sequential scanning techniques of five body levels with time consuming coil rearrangement and repositioning of the patient.
  • Whole-body MRI represents a new alternative to the stepwise multimodality concept for the detection of metastatic disease, multiple myeloma and lymphoma of the bone with high diagnostic accuracy.
  • [MeSH-major] Bone Marrow Neoplasms / diagnosis. Magnetic Resonance Imaging / methods
  • [MeSH-minor] Bone Neoplasms / diagnosis. Bone Neoplasms / secondary. Diagnosis, Differential. Humans. Neoplasm Metastasis / diagnosis. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15950099.001).
  • [ISSN] 0720-048X
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Ireland
  • [Number-of-references] 40
  •  go-up   go-down


46. Henry CJ, Brewer WG Jr, Whitley EM, Tyler JW, Ogilvie GK, Norris A, Fox LE, Morrison WB, Hammer A, Vail DM, Berg J, Veterinary Cooperative Oncology Group (VCOG): Canine digital tumors: a veterinary cooperative oncology group retrospective study of 64 dogs. J Vet Intern Med; 2005 Sep-Oct;19(5):720-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Canine digital tumors: a veterinary cooperative oncology group retrospective study of 64 dogs.
  • We compared clinical characteristics and outcomes for dogs with various digital tumors.
  • Risk factors examined included age, weight, sex, tumor site (hindlimb or forelimb), local tumor (T) stage, metastases, tumor type, and treatment modality.
  • Squamous cell carcinoma (SCC) accounted for 33 (51.6%) of the tumors.
  • Other diagnoses included malignant melanoma (MM) (n = 10; 15.6%), osteosarcoma (OSA) (n = 4; 6.3%), hemangiopericytoma (n = 3; 4.7%), benign soft tissue tumors (n = 5; 7.8%), and malignant soft tissue tumors (n = 9; 14%).
  • None of the patient variables assessed, including age, sex, tumor type, site, and stage, had a significant impact on ST.
  • Although metastasis at diagnosis correlated with a shorter LDFI, it did not have a significant impact on ST.
  • On the basis of these findings, early surgical intervention is advised for the treatment of dogs with digital tumors, regardless of tumor type or the presence of metastatic disease.


47. Abula A, Abaiyedula A, Yusufu A, Liu C, Huang H: [Preliminary clinical application of cancellous granule-type calcium phosphate cement]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Sep;24(9):1100-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To investigate the clinical efficacy of the cancellous granule-type calcium phosphate cement in repair bone defect.
  • METHODS: Between July 2008 and July 2009, 35 patients (42 limbs) with fractures, nonunion, and benign bone tumor were treated with cancellous granule-type calcium phosphate cement.
  • There were 32 males and 3 females, with an age range from 9 to 73 years (median, 41 years), including 24 limb fractures (19 cases), 4 osteotomy for deformity of ulna and radius (2 cases), 2 femur intertrochanteric bony cysts (2 cases), 3 enchondroma (3 cases), 5 bone defect at donor ilium (5 cases), 3 nonunion (3 cases), and 1 lumbar spinal stenosis (1 case).
  • The size of bone defect was 1-5 cm.
  • Bone defect was repaired with cancellous granule-type calcium phosphate cement (1-5 g).
  • Incision dehiscence occurred in 2 cases, and wounds healed after second debridement and removal of artificial bone.
  • X-ray films showed that bone graft fusion was achieved and bone defect was radically repaired at 6 months after operation and artificial bone was absorbed completely at 12 months.
  • CONCLUSION: Cancellous granule-type calcium phosphate cement can be used as a new graft bone material, which is suitable for defect filling after traumatic fracture, benign bone tumors, and iliac bone donor.
  • [MeSH-major] Bone Cements. Bone Transplantation / instrumentation. Calcium Phosphates / therapeutic use

  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20939483.001).
  • [ISSN] 1002-1892
  • [Journal-full-title] Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
  • [ISO-abbreviation] Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Bone Cements; 0 / Calcium Phosphates; 97Z1WI3NDX / calcium phosphate
  •  go-up   go-down


48. Zarei F, Iranpour P: Pneumatocyst, mimicking a sclerotic bony lesion on magnetic resonance imaging. Spine J; 2010 Apr;10(4):e17-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND CONTEXT: Intravertebral pneumatocyst is an uncommon benign lesion, not related to conditions, such as osteomyelitis and postsurgical state, with only a few cases reported in the literature.
  • Considering the signal characteristics, initial diagnosis of sclerosis was made.
  • Correlation with cervical computed tomography scan showed the lesion being of air density, compatible with the diagnosis of pneumatocyst.
  • CONCLUSION: Intraosseous pneumatocyst of cervical spine is a benign finding, which needs no specific treatment; however, it must be included in the differential diagnosis of lucent vertebral lesions seen on conventional radiography and should be differentiated from bony neoplasm and osteomyelitis by its characteristic imaging findings.
  • [MeSH-major] Bone Cysts / pathology. Cervical Vertebrae / pathology. Magnetic Resonance Imaging. Neck Pain / pathology. Spinal Diseases / pathology
  • [MeSH-minor] Diagnosis, Differential. Female. Gases. Humans. Middle Aged. Paresthesia / pathology. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • MedlinePlus Health Information. consumer health - Spine Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20362243.001).
  • [ISSN] 1878-1632
  • [Journal-full-title] The spine journal : official journal of the North American Spine Society
  • [ISO-abbreviation] Spine J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Gases
  •  go-up   go-down


49. Jonathan A, Rajshekhar V, Chacko G: Chondromyxoid fibroma of the seventh cervical vertebra. Neurol India; 2008 Jan-Mar;56(1):84-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chondromyxoid fibroma is a rare benign bone tumor representing less than 0.5% of all bone tumors.
  • A presumptive diagnosis of a bony tumor such as an aneurysmal bone cyst or a giant cell tumor involving the seventh vertebral body was made on plain X-rays, MRI and bone scan.
  • He underwent C7 central corpectomy, incomplete intralesional curettage with iliac bone grafting and C6 to T1 interspinous wiring.
  • The histological diagnosis was chondromyxoid fibroma.
  • On eight years' follow-up, CT scan showed no progression of the tumor with good alignment and fusion of the graft at the site of the corpectomy.
  • The authors conclude that corpectomy and iliac bone grafting for chondromyxoid fibroma has a good outcome on long-term follow-up.
  • [MeSH-major] Bone Neoplasms / complications. Bone Neoplasms / pathology. Cervical Vertebrae / pathology. Chondromatosis / complications. Fibroma / complications. Fibroma / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18310848.001).
  • [ISSN] 0028-3886
  • [Journal-full-title] Neurology India
  • [ISO-abbreviation] Neurol India
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


50. Abdel MP, Papagelopoulos PJ, Morrey ME, Wenger DE, Rose PS, Sim FH: Surgical management of 121 benign proximal fibula tumors. Clin Orthop Relat Res; 2010 Nov;468(11):3056-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical management of 121 benign proximal fibula tumors.
  • BACKGROUND: Tumors of the fibula comprise only 2.5% of primary bone lesions.
  • Patients with aggressive benign tumors in the proximal fibula may require en bloc resection.
  • QUESTIONS/PURPOSES: We therefore analyzed the incidence of peroneal nerve palsy, knee stability, and local recurrence following surgical treatment of benign proximal fibula tumors.
  • METHODS: We retrospectively reviewed the charts of 120 patients (121 tumors) with histologically confirmed aggressive benign tumors of the proximal fibula.
  • The most common diagnosis was osteochondroma (38%) followed by giant cell tumor (19%).
  • Of the 121 tumors, 56 (46%) underwent en bloc resection.
  • CONCLUSIONS: Given the higher recurrence rate with curettage, patients with aggressive proximal fibula tumors benefit from en bloc resection.
  • [MeSH-major] Bone Neoplasms / surgery. Fibula / surgery. Orthopedic Procedures / adverse effects
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Curettage / adverse effects. Female. Humans. Joint Instability / etiology. Joint Instability / physiopathology. Knee Joint / physiopathology. Male. Middle Aged. Neoplasm Recurrence, Local. Osteotomy / adverse effects. Peroneal Neuropathies / etiology. Range of Motion, Articular. Retrospective Studies. Surgical Wound Dehiscence / etiology. Time Factors. Treatment Outcome. Venous Thrombosis / etiology. Young Adult

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 2002 Sep;(402):110-21 [12218476.001]
  • [Cites] Clin Orthop Relat Res. 2007 Jan;454:198-201 [16936590.001]
  • [Cites] Surgery. 1968 Apr;63(4):588-98 [5645375.001]
  • [Cites] Surgery. 1974 Mar;75(3):377-82 [4811333.001]
  • [Cites] J Bone Joint Surg Am. 1981 Oct;63(8):1257-69 [7287796.001]
  • [Cites] J Bone Joint Surg Am. 1982 Jun;64(5):755-61 [7045129.001]
  • [Cites] Am J Sports Med. 1983 Nov-Dec;11(6):404-11 [6650718.001]
  • [Cites] J Bone Joint Surg Am. 1984 Feb;66(2):269-74 [6693454.001]
  • [Cites] Clin Orthop Relat Res. 1984 Jun;(186):172-81 [6723139.001]
  • [Cites] J Bone Joint Surg Am. 1986 Feb;68(2):235-42 [3511063.001]
  • [Cites] J Bone Joint Surg Am. 1986 Jun;68(5):687-94 [3722225.001]
  • [Cites] Cancer. 1987 Apr 1;59(7):1376-85 [3815310.001]
  • [Cites] J Orthop Res. 1988;6(5):621-9 [3404318.001]
  • [Cites] J Bone Joint Surg Br. 1990 Jul;72(4):723-4 [2380235.001]
  • [Cites] J Bone Joint Surg Am. 1991 Apr;73(4):575-83 [2013596.001]
  • [Cites] Clin Orthop Relat Res. 1991 Jun;(267):197-201 [2044277.001]
  • [Cites] J Bone Joint Surg Am. 1992 Sep;74(8):1180-5 [1400546.001]
  • [Cites] J Bone Joint Surg Am. 1993 Nov;75(11):1648-55 [8245057.001]
  • [Cites] J Surg Oncol. 1996 Jan;61(1):34-7 [8544457.001]
  • [Cites] J Bone Joint Surg Am. 1996 Feb;78(2):204-11 [8609110.001]
  • [Cites] Knee. 2004 Dec;11(6):489-96 [15581770.001]
  • [Cites] Arch Orthop Trauma Surg. 2005 Dec;125(10):713-20 [16267651.001]
  • [Cites] Clin Orthop Relat Res. 2003 Jan;(406):136-40 [12579012.001]
  • (PMID = 20625947.001).
  • [ISSN] 1528-1132
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2947668
  •  go-up   go-down


51. Fukunaga S, Futani H, Yoshiya S: Endoscopically assisted resection of a scapular osteochondroma causing snapping scapula syndrome. World J Surg Oncol; 2007;5:37
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Osteochondroma is the most common benign bone tumor in the scapula.
  • Removal of the tumor was performed by the use of endoscopically assisted resection.
  • The tumor was resected in a piece-by-piece manner by the use of graspers through the same portal.
  • CT images showed complete tumor resection.
  • [MeSH-major] Bone Neoplasms / surgery. Endoscopy. Osteochondroma / surgery. Scapula

  • Genetic Alliance. consumer health - Osteochondroma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Phys Med Rehabil. 1997 May;78(5):506-11 [9161370.001]
  • [Cites] J Shoulder Elbow Surg. 1999 Jan-Feb;8(1):53-7 [10077798.001]
  • [Cites] Clin Orthop. 1961;20:139-50 [13770600.001]
  • [Cites] Orthopedics. 2005 Feb;28(2):171-2 [15751374.001]
  • [Cites] Acta Orthop Scand. 1999 Aug;70(4):394-6 [10569273.001]
  • [Cites] J Pediatr Orthop. 1995 Sep-Oct;15(5):578-81 [7593565.001]
  • [Cites] Arthroscopy. 2002 May-Jun;18(5):23E [11987048.001]
  • [Cites] Clin Orthop Relat Res. 1968 May-Jun;58:105-15 [4299856.001]
  • [Cites] J Bone Joint Surg Br. 1973 May;55(2):345-9 [4707302.001]
  • [Cites] Arthroscopy. 1995 Feb;11(1):106-11 [7727002.001]
  • [Cites] Arthroscopy. 1995 Feb;11(1):52-6 [7727012.001]
  • [Cites] AJR Am J Roentgenol. 2000 Jun;174(6):1729-35 [10845514.001]
  • (PMID = 17378939.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1839090
  • [General-notes] NLM/ Original DateCompleted: 20070726
  •  go-up   go-down


52. Murphey MD: World Health Organization classification of bone and soft tissue tumors: modifications and implications for radiologists. Semin Musculoskelet Radiol; 2007 Sep;11(3):201-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] World Health Organization classification of bone and soft tissue tumors: modifications and implications for radiologists.
  • The working group of the World Health Organization (WHO) for classification of tumors of soft tissue and bone met in 2002.
  • The consensus of this conference led to modifications in the nomenclature primarily for soft tissue neoplasm, leaving osseous tumors largely unaltered.
  • This allows improved uniformity in our discussions with pathologists and orthopedic oncologists in our team approach in the diagnosis and treatment of these patients.
  • [MeSH-major] Bone Neoplasms / classification. Diagnostic Imaging. Soft Tissue Neoplasms / classification. World Health Organization
  • [MeSH-minor] Fibrosarcoma / classification. Histiocytoma, Benign Fibrous / classification. Humans. Liposarcoma / classification. Terminology as Topic


53. Bostan B, Sen C, Gunes T, Erdem M, Koseoglu RD: Osteoid osteoma of the trapezium: case report. J Hand Surg Am; 2010 Apr;35(4):636-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoid osteoma is a benign bone tumor representing approximately 10% of all benign bone tumors.
  • [MeSH-major] Bone Neoplasms / diagnosis. Osteoma, Osteoid / diagnosis. Trapezium Bone / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Diagnostic Imaging. Humans. Male

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20171814.001).
  • [ISSN] 1531-6564
  • [Journal-full-title] The Journal of hand surgery
  • [ISO-abbreviation] J Hand Surg Am
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


54. Singh R, Jain M, Siwach R, Rohilla RK, Kaur K: Unusual presentation of bizarre parosteal osteochondromatous lesion of the second toe (Nora's lesion). Foot Ankle Spec; 2010 Dec;3(6):347-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Bizarre parosteal osteochondromatous proliferation (BPOP) of bone is a rare benign neoplasm.
  • Although local excision of the tumor is the treatment of choice, the authors resorted to ray excision, as gangrenous changes and ulceration were present and there was the possibility of malignant change.
  • [MeSH-major] Bone Neoplasms / pathology. Foot Ulcer / pathology. Osteochondroma / pathology. Periosteum / pathology. Toes / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20624925.001).
  • [ISSN] 1938-7636
  • [Journal-full-title] Foot & ankle specialist
  • [ISO-abbreviation] Foot Ankle Spec
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Brochard C, Michalak S, Aubé C, Singeorzan C, Fournier HD, Laccourreye L, Calès P, Boursier J: A not so solitary fibrous tumor of the liver. Gastroenterol Clin Biol; 2010 Dec;34(12):716-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A not so solitary fibrous tumor of the liver.
  • Solitary fibrous tumor (SFT) is a rare neoplasm.
  • Liver parenchyma is a rare location of SFT and, in this case, it usually follows a benign course.
  • We report here the case of a 54-year-old man who presented a large SFT tumor of the right hepatic lobe.
  • The tumor was surgically resected.
  • Local recurrence occurred 6 years later as a 15 cm diameter liver tumor.
  • Two years later, the patient presented with complaints of neck pain and ensuing examinations revealed a tumor of the cranial base.
  • Few weeks later, the patient presented an irreducible psoitis due to an iliac bone metastasis.
  • [MeSH-major] Liver Neoplasms / pathology. Skull Base Neoplasms / secondary. Solitary Fibrous Tumors / secondary

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 20864281.001).
  • [ISSN] 0399-8320
  • [Journal-full-title] Gastroentérologie clinique et biologique
  • [ISO-abbreviation] Gastroenterol. Clin. Biol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


56. Mir NA, Baba AN, Maajid S, Badoo AR, Mir GR: Osteoblastoma of body of the talus--Report of a rare case with atypical radiological features. Foot Ankle Surg; 2010 Jun;16(2):e24-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoblastoma is a benign bone tumour found commonly in the spine and long tubular bones.
  • Analysis of clinical, radiological and histological findings confirmed the diagnosis of osteoblastoma.
  • [MeSH-major] Bone Neoplasms / radiography. Osteoblastoma / radiography. Rare Diseases. Talus. Tomography, X-Ray Computed
  • [MeSH-minor] Adolescent. Diagnosis, Differential. Follow-Up Studies. Humans. Male. Osteotomy / methods

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Rare Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20483122.001).
  • [ISSN] 1460-9584
  • [Journal-full-title] Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons
  • [ISO-abbreviation] Foot Ankle Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


57. Jundt G, Baumhoer D: [Hereditary bone tumors]. Pathologe; 2010 Oct;31(6):471-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Hereditary bone tumors].
  • Familial diseases leading to bone tumor formation are rare.
  • This leads to multiple benign bone tumors, which may undergo secondary malignant transformation (enchondromatosis: enchondromas, multiple hereditary exostoses: osteochondromas) or bone sarcomas, mainly osteosarcomas, such as primary (Li-Fraumeni, Rothmund-Thomson, Werner and Bloom syndromes) or secondary manifestations (retinoblastoma syndrome) of the underlying disease.
  • In contrast to sporadically occurring similar tumors, differences in manifestation in time, topography or histology may be present which can aid in the correct recognition of the underlying syndrome.
  • [MeSH-major] Bone Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Natl Cancer Inst. 2003 May 7;95(9):669-74 [12734318.001]
  • [Cites] Cancer Res. 2003 Oct 15;63(20):6643-50 [14583457.001]
  • [Cites] J Clin Oncol. 1999 Apr;17(4):1164 [10561175.001]
  • [Cites] Ophthalmologe. 2006 Jan;103(1):59-76; quiz 77-8 [16382314.001]
  • [Cites] Nat Genet. 2002 Mar;30(3):306-10 [11850620.001]
  • [Cites] N Engl J Med. 1987 Sep 3;317(10):588-93 [3475572.001]
  • [Cites] Orphanet J Rare Dis. 2006 Sep 22;1:37 [16995932.001]
  • [Cites] Eur J Cancer. 2006 Sep;42(14):2343-9 [16859907.001]
  • [Cites] J Med Genet. 2001 Jul;38(7):430-4 [11432960.001]
  • [Cites] AMA Am J Dis Child. 1954 Dec;88(6):754-8 [13206391.001]
  • [Cites] J Clin Oncol. 2009 Mar 10;27(8):1250-6 [19204208.001]
  • [Cites] Ophthalmic Genet. 2001 Jun;22(2):77-88 [11449317.001]
  • [Cites] Am J Med Genet. 2001 Jul 22;102(1):11-7 [11471165.001]
  • [Cites] J Clin Oncol. 2009 Sep 10;27(26):e108-9; author reply e110 [19652052.001]
  • [Cites] Cancer Res. 1994 Mar 1;54(5):1298-304 [8118819.001]
  • [Cites] Hum Genet. 2008 Nov;124(4):369-77 [18810497.001]
  • [Cites] Eur J Hum Genet. 2003 Aug;11(8):611-8 [12891382.001]
  • [Cites] Hum Mol Genet. 2008 Sep 15;17(18):2766-75 [18559376.001]
  • [Cites] Int J Clin Exp Pathol. 2010 Jun 26;3(6):557-69 [20661403.001]
  • [Cites] Nat Rev Cancer. 2009 Sep;9(9):644-54 [19657341.001]
  • [Cites] Neurosurgery. 2009 Dec;65(6):1106-13; discussion 1113-5 [19934970.001]
  • [Cites] Virchows Arch. 2006 Oct;449(4):495-7 [16941149.001]
  • [Cites] Hum Mutat. 2004 Dec;24(6):466-73 [15523647.001]
  • [Cites] Biochimie. 2003 Nov;85(11):1185-93 [14726023.001]
  • [Cites] J Bone Joint Surg Am. 1987 Feb;69(2):269-74 [3805090.001]
  • [Cites] Br J Ophthalmol. 2009 Sep;93(9):1159-62 [19704040.001]
  • [Cites] Orphanet J Rare Dis. 2008 Feb 13;3:3 [18271966.001]
  • [Cites] Jpn J Cancer Res. 2000 Dec;91(12):1345-9 [11123436.001]
  • [Cites] Eur J Radiol. 2001 Jun;38(3):235-48 [11399379.001]
  • [Cites] Cancer Res. 1988 Sep 15;48(18):5358-62 [3409256.001]
  • (PMID = 20960198.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


58. Dierselhuis EF, Jutte PC, van der Eerden PJ, Suurmeijer AJ, Bulstra SK: Hip fracture after radiofrequency ablation therapy for bone tumors: two case reports. Skeletal Radiol; 2010 Nov;39(11):1139-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hip fracture after radiofrequency ablation therapy for bone tumors: two case reports.
  • In orthopedic surgery, RFA is used for the treatment of benign bone tumors and bone metastases.
  • Complications are rare and, to our knowledge, bone fracture as a complication due solely to RFA has not been reported to date.
  • In this report we describe two patients with a fracture in the calcar region of the femur as a complication of RFA treatment for bone malignancies.
  • [MeSH-major] Bone Neoplasms / diagnosis. Bone Neoplasms / surgery. Catheter Ablation / adverse effects. Femoral Fractures / diagnosis. Femoral Fractures / etiology. Magnetic Resonance Imaging. Tomography, X-Ray Computed


59. Cabrera RA, Almeida M, Mendonça ME, Frable WJ: Diagnostic pitfalls in fine-needle aspiration cytology of temporomandibular chondroblastoma: report of two cases. Diagn Cytopathol; 2006 Jun;34(6):424-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chondroblastoma is a benign bone neoplasm, which usually presents in the epiphysis of long bones, but can occur in unusual locations.
  • This emphasizes the diagnostic pitfalls of this entity and expands the cytologic differential diagnosis of tumors of the parotid region.
  • [MeSH-major] Biopsy, Fine-Needle. Bone Neoplasms / diagnosis. Chondroblastoma / diagnosis. Mandible / pathology. Temporal Bone / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Parotid Neoplasms / pathology. Synovitis, Pigmented Villonodular / pathology

  • Genetic Alliance. consumer health - Chondroblastoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16680777.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


60. Kelly RJ, Barrett C, Swan N, McDermott R: Metastatic phyllodes tumor causing small-bowel obstruction. Clin Breast Cancer; 2009 Aug;9(3):193-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic phyllodes tumor causing small-bowel obstruction.
  • Cystosarcoma phyllodes is an important but relatively uncommon fibroepithelial breast neoplasm that accounts for 0.5%-1.0% of female breast carcinomas.
  • These usually metastasize to the lung, pleura, bone, and liver.
  • This report highlights a unique case of a metastatic phyllodes breast tumor leading to small bowel obstruction.
  • Phyllodes tumors are generally classified into histologic subtypes of benign, intermediate, and malignant, using agreed classification systems.
  • The tumor characteristics that can lead to the dedifferentiation of a relatively benign phenotype to an overt malignant process are discussed.
  • [MeSH-major] Breast Neoplasms / pathology. Ileal Neoplasms / secondary. Intestinal Obstruction / etiology. Phyllodes Tumor / pathology
  • [MeSH-minor] Antibiotics, Antineoplastic / administration & dosage. Antineoplastic Agents, Alkylating / administration & dosage. Combined Modality Therapy. Doxorubicin / administration & dosage. Female. Humans. Ifosfamide / administration & dosage. Mastectomy. Middle Aged. Neoplasm Recurrence, Local

  • Genetic Alliance. consumer health - Phyllodes Tumor.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • MedlinePlus Health Information. consumer health - Intestinal Obstruction.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19661046.001).
  • [ISSN] 1938-0666
  • [Journal-full-title] Clinical breast cancer
  • [ISO-abbreviation] Clin. Breast Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 0 / Antineoplastic Agents, Alkylating; 80168379AG / Doxorubicin; UM20QQM95Y / Ifosfamide
  •  go-up   go-down


61. Theumann N, Hauser P, Schmidt S, Schnyder P, Leyvraz PF, Mouhsine E: [Osteoid osteoma and radiofrequency]. Rev Med Suisse; 2005 Dec 21;1(46):2989-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Thermoablation par radiofréquence de l'ostéome ostéoïde.
  • Osteoid osteoma and radiofrequency Osteoid osteoma relates to a benign skeletal neoplasm, smaller than 2 cm in diameter, composed of osteoid, highly vascularized connective tissue and surrounded by a ring of bone sclerosis.
  • [MeSH-major] Bone Neoplasms / surgery. Catheter Ablation / methods. Osteoma, Osteoid / surgery

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16429972.001).
  • [ISSN] 1660-9379
  • [Journal-full-title] Revue médicale suisse
  • [ISO-abbreviation] Rev Med Suisse
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Salicylates
  • [Number-of-references] 12
  •  go-up   go-down


62. Jeon DG, Lee SY, Kim JW: Bone primary sarcomas undergone unplanned intralesional procedures - the possibility of limb salvage and their oncologic results. J Surg Oncol; 2006 Dec 1;94(7):592-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bone primary sarcomas undergone unplanned intralesional procedures - the possibility of limb salvage and their oncologic results.
  • BACKGROUND: It is quite rare but some primary sarcomas of the bone can be misdiagnosed as benign and be treated using intralesional procedures.
  • An unplanned surgical excision occurs when tumors are removed without the appropriate preoperative evaluation and consideration for the need to obtain tumor-free margins.
  • Residual tumor tissue as a result of unplanned excision of soft tissue sarcoma is a risk factor for local recurrence.
  • There were 22 (88%) cases of osteosarcomas, 2 (8%) MFH of bone and 1 (4%) adamantinoma.
  • Limb salvage procedures are worthwhile in cases whose initial radiographic findings simulate benign lesions, showing favorable response to neoadjuvant chemotherapy.
  • [MeSH-major] Bone Neoplasms / surgery. Limb Salvage. Osteosarcoma / surgery. Sarcoma / surgery
  • [MeSH-minor] Adolescent. Adult. Chemotherapy, Adjuvant. Curettage. Female. Humans. Lower Extremity / surgery. Male. Middle Aged. Neoplasm Recurrence, Local. Soft Tissue Neoplasms / mortality. Soft Tissue Neoplasms / surgery. Survival Rate. Treatment Outcome


63. Jeys LM, Suneja R, Chami G, Grimer RJ, Carter SR, Tillman RM: Impending fractures in giant cell tumours of the distal femur: incidence and outcome. Int Orthop; 2006 Apr;30(2):135-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Impending fractures in giant cell tumours of the distal femur: incidence and outcome.
  • Giant cell tumours are rare bone tumours that are characteristically benign but locally aggressive, most frequently occurring in the distal femur with pathological fractures being common.
  • This paper investigates relationships between tumour size and cortical breach on initial X-rays and subsequent treatment.
  • The X-rays of 54 patients with distal femoral giant cell tumours were reviewed.
  • The volumes of the tumour, distal femur and a ratio between the two parameters were estimated.
  • There was a significant difference in the ratio of tumour volume to distal femoral volume between the discrete fracture group and the cortical breach group.
  • [MeSH-major] Femoral Fractures / epidemiology. Femoral Fractures / physiopathology. Femoral Neoplasms / physiopathology. Giant Cell Tumor of Bone / physiopathology
  • [MeSH-minor] Adolescent. Adult. Aged. Analysis of Variance. Female. Humans. Incidence. Male. Middle Aged. Neoplasm Recurrence, Local. Prospective Studies. Risk Factors

  • MedlinePlus Health Information. consumer health - Leg Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 2002 Apr;(397):248-58 [11953616.001]
  • [Cites] J Bone Joint Surg Br. 2004 Jan;86(1):5-12 [14765857.001]
  • [Cites] J Bone Joint Surg Am. 1970 Jun;52(4):619-64 [5479455.001]
  • [Cites] J Bone Joint Surg Am. 1975 Mar;57(2):167-73 [1112843.001]
  • [Cites] J Bone Joint Surg Am. 1976 Dec;58(8):1047-55 [1002744.001]
  • [Cites] J Bone Joint Surg Am. 1982 Jun;64(5):755-61 [7045129.001]
  • [Cites] J Bone Joint Surg Br. 1995 Mar;77(2):189-93 [7706330.001]
  • [Cites] Clin Orthop Relat Res. 1986 Feb;(203):282-8 [3955991.001]
  • [Cites] Arch Orthop Trauma Surg. 1986;105(2):67-72 [3718192.001]
  • [Cites] J Bone Joint Surg Am. 1987 Jan;69(1):106-14 [3805057.001]
  • [Cites] Clin Orthop Relat Res. 1989 Dec;(249):256-64 [2684463.001]
  • [Cites] Chir Organi Mov. 1990;75(1 Suppl):203 [2249532.001]
  • [Cites] Chir Organi Mov. 1990;75(1 Suppl):241-3 [2249540.001]
  • [Cites] J Bone Joint Surg Am. 1986 Feb;68(2):235-42 [3511063.001]
  • (PMID = 16474936.001).
  • [ISSN] 0341-2695
  • [Journal-full-title] International orthopaedics
  • [ISO-abbreviation] Int Orthop
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Other-IDs] NLM/ PMC2532068
  •  go-up   go-down


64. Miettinen M, Finnell V, Fetsch JF: Ossifying fibromyxoid tumor of soft parts--a clinicopathologic and immunohistochemical study of 104 cases with long-term follow-up and a critical review of the literature. Am J Surg Pathol; 2008 Jul;32(7):996-1005
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ossifying fibromyxoid tumor of soft parts--a clinicopathologic and immunohistochemical study of 104 cases with long-term follow-up and a critical review of the literature.
  • Ossifying fibromyxoid tumor (OFT) is a unique soft tissue tumor of uncertain histogenesis.
  • The majority of reported cases (approximately 220) have pursued a benign clinical course.
  • However, recent literature has emphasized the existence of morphologically atypical and clinically malignant examples of this tumor and proposed guidelines for assessment of biologic potential.
  • Herein, OFT was strictly defined as a tumor with lobular architecture, predominantly epithelioid cell morphology, a low level of atypia, corded and trabecular growth patterns, moderate amounts of myxocollagenous matrix, and often, focal peripheral metaplastic bone formation.
  • Tumors that lacked conventional morphology were excluded.
  • The exclusion group included cutaneous mixed tumors, low-grade fibromyxoid sarcomas, and extraskeletal osteosarcomas.
  • The tumor size ranged from 0.7 to 17 cm (median, 3 cm).
  • Tumor cell nuclei typically contained small, distinct nucleoli, and necrosis was infrequent (11/104).
  • The great majority of tumors (67/71, 94%) were positive for S100 protein, whereas only occasional examples had (focal) positivity for desmin, glial fibrillary acidic protein, and an AE1/AE3 keratin cocktail.
  • A mitotic rate of >2 mitotic figures/50 HPFs was a risk factor for local recurrence, but necrosis, tumor size, the presence of satellite nodules, and positive margins were not.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Cell Nucleus / pathology. Disease-Free Survival. Female. Humans. Male. Middle Aged. Mitosis. Neoplasm Recurrence, Local. S100 Proteins / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18469710.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / S100 Proteins
  •  go-up   go-down


65. Narita T, Ishii N, Mayuzumi H, Kobayashi H, Ikeda J, Iwasaki Y: Occipitoparietal benign osteoblastoma: should entire lesion be resected when magnetic resonance images reveal wide abnormal signal intensity in surrounding bone marrow? Surg Neurol; 2005 Aug;64(2):180-3; discussion 184
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Occipitoparietal benign osteoblastoma: should entire lesion be resected when magnetic resonance images reveal wide abnormal signal intensity in surrounding bone marrow?
  • BACKGROUND: Benign osteoblastoma is an uncommon primary bone tumor that usually affects long bones and the vertebral column.
  • Despite the characteristically benign nomenclature of osteoblastoma, it sometimes recurs with the possibility of transforming into a malignant form after an incomplete resection.
  • However, it has not been clarified whether the adjacent bones should also be completely resected when magnetic resonance (MR) images reveal abnormal signal intensity in the bone marrow.
  • CASE DESCRIPTION: Presented in this case report is a 12-year-old boy with occipital tenderness associated with occipitoparietal bone tumor.
  • Neuroradiological studies demonstrated a solid tumor located in the occipital bone extending over the right parietal bone.
  • Magnetic resonance images further revealed abnormal signal intensity in the bone marrow of the entire occipital and bilateral parietal bones.
  • Macroscopically, the calvarial bone adjacent to the solid tumor appeared to be reddish, but it was not covering the entire area, contradicting the abnormal intensity found on the preoperative MR images.
  • Because histological examination did not clearly indicate tumor invasion at the margin of the resection site, no additional therapy was given.
  • Although MR images revealed abnormal intensity in the bone marrow of the surgical margin immediately after the operation, the intensity had been normalized by degrees and there was no evidence of recurrence during a follow-up period of 34 months.
  • This may suggest that bone marrow lesion showing abnormal intensity was edema rather than tumor invasion.
  • CONCLUSIONS: The authors conclude that total resection, including a bone marrow lesion, is not always necessary for benign osteoblastoma.
  • Macroscopic findings that show an abnormal color tone of the cortex could be a good indicator in revealing tumor activity invading bone marrow.
  • [MeSH-major] Magnetic Resonance Imaging. Occipital Bone / pathology. Osteoblastoma / pathology. Osteoblastoma / surgery. Skull Neoplasms / pathology. Skull Neoplasms / surgery
  • [MeSH-minor] Bone Marrow Neoplasms / pathology. Child. Humans. Male. Neoplasm Invasiveness. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16051019.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


66. Moskovszky L, Dezsö K, Athanasou N, Szendröi M, Kopper L, Kliskey K, Picci P, Sápi Z: Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability. Mod Pathol; 2010 Mar;23(3):359-66
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability.
  • Giant cell tumour of bone, a benign but potentially aggressive neoplasm, shows an increasing rate of chromosomal aneusomy that correlates with clinical course.
  • Mechanisms that generate chromosomal instability in giant cell tumour of bone are poorly understood.
  • To gain an insight into the possible mechanism for the generation of chromosomal instability in giant cell tumour of bone, we analysed 100 cases, including 57 primary nonrecurrent, 35 recurrent and 8 malignant giant cell tumour of bone cases. gamma-Tubulin immunohistochemistry was performed on tissue microarrays of 59 formalin-fixed paraffin-embedded cases, whereas pericentrin and gamma-tubulin fluorescent immunocytochemistry was carried out on 41 frozen smears.
  • Centrosome amplification was significantly higher in recurrent and malignant giant cell tumour of bones compared with nonrecurrent tumours (P<0.001).
  • These findings indicate that centrosome alteration and frequency of aneusomy correlate with clinical behaviour; the lack of an association between centrosome amplification and chromosome number alteration suggests that alternative causative mechanisms produce genetic instability in giant cell tumour of bone.
  • [MeSH-major] Bone Neoplasms / genetics. Centrosome / pathology. Chromosomal Instability. Giant Cell Tumor of Bone / genetics

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20062006.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens; 0 / Tubulin; 0 / pericentrin
  •  go-up   go-down


67. Hauptmann K, Melcher I, Schaser KD: [Differential diagnosis of intramedullary osteosarcomas]. Pathologe; 2008 Nov;29 Suppl 2:240-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Differential diagnosis of intramedullary osteosarcomas].
  • Intramedullary high-grade osteosarcomas are aggressive tumors with a high metastatic capacity.
  • The many subtypes and variants of these tumors often make the differential diagnosis difficult.
  • Low-grade central osteosarcomas are a completely different tumor group.
  • Due to their strong similarity to benign bone tumors they are frequently misdiagnosed as such.
  • The correct diagnosis followed by radical surgery, however, is essential to reduce the high risk of local recurrences, typically seen for of these lesions.
  • [MeSH-major] Bone Neoplasms / pathology. Osteosarcoma / pathology
  • [MeSH-minor] Biopsy. Bone and Bones / diagnostic imaging. Bone and Bones / pathology. Diagnosis, Differential. Humans. Neoplasm Recurrence, Local / diagnostic imaging. Neoplasm Recurrence, Local / pathology. Prognosis. Radiography

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 2000 May;31(5):615-8 [10836302.001]
  • [Cites] Skeletal Radiol. 2005 May;34(5):290-4 [15570421.001]
  • [Cites] J Bone Joint Surg Br. 1992 Nov;74(6):883-6 [1447251.001]
  • [Cites] Cancer. 1997 Jun 1;79(11):2095-106 [9179055.001]
  • [Cites] Pediatr Blood Cancer. 2004 Jan;42(1):59-63 [14752796.001]
  • [Cites] Am J Clin Pathol. 2006 Apr;125(4):555-81 [16627266.001]
  • [Cites] Cancer. 2003 Jun 15;97(12):3068-75 [12784343.001]
  • [Cites] Skeletal Radiol. 2000 Nov;29(11):656-9 [11201036.001]
  • [Cites] Clin Orthop Relat Res. 1996 Jan;(322):198-206 [8542697.001]
  • [Cites] J Bone Joint Surg Am. 1979 Mar;61(2):207-15 [284009.001]
  • [Cites] Cancer. 2007 Apr 15;109(8):1627-37 [17351949.001]
  • [Cites] Cancer. 1993 Jan 15;71(2):338-45 [8422626.001]
  • [Cites] Cancer. 1990 Mar 15;65(6):1418-28 [2306687.001]
  • (PMID = 18843492.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 16
  •  go-up   go-down


68. Miller IJ, Blank A, Yin SM, McNickle A, Gray R, Gitelis S: A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases. Diagn Pathol; 2010;5:62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases.
  • Giant cell tumor (GCT) of bone is a locally destructive tumor that occurs predominantly in long bones of post-pubertal adolescents and young adults, where it occurs in the epiphysis.
  • Vascular invasion outside the boundary of the tumor can be seen.
  • Metastasis, with identical morphology to the primary tumor, occurs in a few percent of cases, usually to the lung.
  • On occasion GCTs of bone undergo frank malignant transformation to undifferentiated sarcomas.
  • Here we report a case of GCT of bone that at the time of recurrence was found to have undergone malignant transformation.
  • [MeSH-major] Bone Neoplasms / pathology. Cell Transformation, Neoplastic / pathology. Giant Cell Tumor of Bone / secondary. Lung Neoplasms / secondary. Neoplasm Recurrence, Local. Tibia / pathology
  • [MeSH-minor] Adult. Arthroplasty, Replacement, Knee. Biopsy. Bone Cements / therapeutic use. Chemotherapy, Adjuvant. Curettage. Humans. Immunohistochemistry. Male. Neoadjuvant Therapy. Reoperation. Thoracoscopy. Tomography, X-Ray Computed. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Miner Res. 2000 Apr;15(4):640-9 [10780856.001]
  • [Cites] Ann Surg Oncol. 2010 Mar;17(3):694-701 [19902306.001]
  • [Cites] Clin Orthop Relat Res. 2002 Apr;(397):248-58 [11953616.001]
  • [Cites] Cancer. 2003 May 15;97(10):2520-9 [12733152.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):158-65 [12909228.001]
  • [Cites] J Bone Joint Surg Br. 2004 Mar;86(2):212-6 [15046435.001]
  • [Cites] Int Orthop. 2004 Aug;28(4):239-43 [15160253.001]
  • [Cites] Cancer. 1970 May;25(5):1061-70 [4910256.001]
  • [Cites] J Bone Joint Surg Am. 1986 Sep;68(7):1073-9 [3745247.001]
  • [Cites] Skeletal Radiol. 1997 Apr;26(4):246-55 [9151375.001]
  • [Cites] Int Orthop. 1998;22(1):19-26 [9549577.001]
  • [Cites] Am J Pathol. 2005 Jul;167(1):117-28 [15972958.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):690-5 [16407111.001]
  • [Cites] J Bone Joint Surg Br. 2006 Apr;88(4):531-5 [16567792.001]
  • [Cites] J Bone Joint Surg Am. 2006 Sep;88(9):1998-2008 [16951117.001]
  • [Cites] Int Orthop. 2006 Dec;30(6):499-504 [16909252.001]
  • [Cites] Int Orthop. 2006 Dec;30(6):484-9 [17013643.001]
  • [Cites] Am J Surg Pathol. 2007 Jun;31(6):970-6 [17527089.001]
  • [Cites] J Pathol. 2008 Apr;214(5):555-63 [18278785.001]
  • [Cites] Mod Pathol. 2008 Apr;21(4):369-75 [18311114.001]
  • [Cites] Clin Orthop Relat Res. 2008 Sep;466(9):2081-91 [18543051.001]
  • [Cites] J Cancer Res Clin Oncol. 2008 Sep;134(9):969-78 [18322700.001]
  • [Cites] Genes Chromosomes Cancer. 2009 Jun;48(6):468-79 [19242928.001]
  • [Cites] Curr Opin Oncol. 2009 Jul;21(4):338-44 [19444102.001]
  • [Cites] Genes Chromosomes Cancer. 2009 Jul;48(7):583-602 [19396867.001]
  • [Cites] Zhonghua Bing Li Xue Za Zhi. 2009 May;38(5):312-5 [19575873.001]
  • [Cites] Clin Orthop Relat Res. 2010 Mar;468(3):827-33 [19597900.001]
  • [Cites] Skeletal Radiol. 2001 Feb;30(2):104-8 [11310196.001]
  • (PMID = 20860830.001).
  • [ISSN] 1746-1596
  • [Journal-full-title] Diagnostic pathology
  • [ISO-abbreviation] Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Bone Cements
  • [Other-IDs] NLM/ PMC2954972
  •  go-up   go-down


69. Romeo S, Bovée JV, Grogan SP, Taminiau AH, Eilers PH, Cleton-Jansen AM, Mainil-Varlet P, Hogendoorn PC: Chondromyxoid fibroma resembles in vitro chondrogenesis, but differs in expression of signalling molecules. J Pathol; 2005 Jun;206(2):135-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chondromyxoid fibroma is a rare benign cartilaginous bone tumour characterized by morphological features that resemble different steps of chondrogenesis in terms of both cellular morphology, ranging from spindled to rounded cells, and the extracellular matrix formed, which ranges from fibrous to cartilaginous.
  • [MeSH-major] Bone Neoplasms / pathology. Chondroblastoma / pathology. Chondrogenesis
  • [MeSH-minor] Cartilage, Articular / cytology. Cell Cycle Proteins / metabolism. Cells, Cultured. Chondrocytes / cytology. Female. Humans. Immunoenzyme Techniques. Male. Neoplasm Proteins / metabolism. Signal Transduction

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Pathological Society of Great Britain and Ireland
  • (PMID = 15880456.001).
  • [ISSN] 0022-3417
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cell Cycle Proteins; 0 / Neoplasm Proteins
  •  go-up   go-down


70. Curnoe D, Brink J: Evidence of pathological conditions in the Florisbad cranium. J Hum Evol; 2010 Nov;59(5):504-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Palaeopathological studies of the middle Pleistocene cranium from Florisbad (Free State, South Africa) document the presence of extensive cortical lesions and areas of thinning, a widened medullary cavity with destruction of the diploë, orbital roof lesions, a benign ectocranial neoplasm, and evidence for alveolar destruction, resorption, and antemortem tooth loss.
  • Differential diagnosis suggests one or more possible aetiologies, including a haematological disorder, metabolic condition(s), Paget's disease of bone, or non-specific infection perhaps following trauma.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20727570.001).
  • [ISSN] 1095-8606
  • [Journal-full-title] Journal of human evolution
  • [ISO-abbreviation] J. Hum. Evol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


71. Angiero F, Mellone P, Baldi A, Stefani M: Osteoblastoma of the jaw: report of two cases and review of the literature. In Vivo; 2006 Sep-Oct;20(5):665-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoblastoma is a benign bone tumor of osteoblastic origin.
  • Both tumors were resected with wide surgical margins and neither patient had adjuvant radiation or chemotherapy.
  • Differential diagnosis and immunohistochemical features potentially useful for refining diagnosis of osteoblastoma are also discussed.
  • [MeSH-major] Biomarkers, Tumor / analysis. Jaw Neoplasms / pathology. Osteoblastoma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17091775.001).
  • [ISSN] 0258-851X
  • [Journal-full-title] In vivo (Athens, Greece)
  • [ISO-abbreviation] In Vivo
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


72. Hod N, Levi Y, Fire G, Cohen I, Ayash D, Somekh M, Horne T: Scintigraphic characteristics of non-ossifying fibroma in military recruits undergoing bone scintigraphy for suspected stress fractures and lower limb pains. Nucl Med Commun; 2007 Jan;28(1):25-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Scintigraphic characteristics of non-ossifying fibroma in military recruits undergoing bone scintigraphy for suspected stress fractures and lower limb pains.
  • INTRODUCTION: Non-ossifying fibroma (NOF) is the most common fibrous bone lesion in children and young adults.
  • This benign lesion is not a true neoplasm but is considered a developmental defect.
  • NOF that ossify can show increased uptake on bone scintigraphy.
  • AIM: To document the scintigraphic features of NOF in a group of military recruits undergoing bone scintigraphy for suspected stress fractures.
  • MATERIALS AND METHODS: Eighty-three military recruits, 67 male and 16 female, aged 18 to 22 years (mean, 19.4 years), who underwent Tc-methylene diphosphonate bone scans for suspected stress fractures or because of pain of the lower limbs had 91 focal lesions on bone scan which on further evaluation demonstrated characteristic radiographic findings of NOF.
  • We evaluated the anatomical site of the lesions, documented the intensity of uptake on bone scan and compared the findings with the radiographic description of the lesions.
  • All the NOF showed variable degrees of focal increased tracer uptake on bone scan.
  • The bone scan appearance of the focal lesions was: faint uptake in 29 (31.9%), mild uptake in 27 (29.7%), moderate uptake in 28 (30.7%) and intensely increased uptake in seven (7.7%).
  • CONCLUSIONS: Military recruits undergoing bone scan for suspected stress fracture might have incidental findings which require further evaluation.
  • Focal lesions on bone scan located about the knee in the lateral aspect of the distal femur or lateral aspect of the proximal tibia in the metaphyseal region of these bones are not compatible with the characteristic scintigraphic features of stress fracture.
  • During the healing phase of the NOF which commonly occur in the age range of this group, the lesion shows mild-to-moderate increased tracer uptake on bone scan.
  • Some NOF lesions are still indistinguishable from stress fracture or splints on bone scan.
  • [MeSH-major] Fibroma / pathology. Fractures, Stress / diagnosis. Ossification, Heterotopic / diagnosis. Radionuclide Imaging / methods
  • [MeSH-minor] Adolescent. Adult. Bone Diseases, Developmental / radiography. Bone and Bones / pathology. Female. Humans. Leg Bones / pathology. Male. Military Personnel. Pain. Radiopharmaceuticals / pharmacology. Technetium / pharmacology

  • MedlinePlus Health Information. consumer health - Nuclear Scans.
  • Hazardous Substances Data Bank. TECHNETIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17159546.001).
  • [ISSN] 0143-3636
  • [Journal-full-title] Nuclear medicine communications
  • [ISO-abbreviation] Nucl Med Commun
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 7440-26-8 / Technetium
  •  go-up   go-down


73. Schaller BJ, Modo M, Buchfelder M: Molecular imaging of brain tumors: a bridge between clinical and molecular medicine? Mol Imaging Biol; 2007 Mar-Apr;9(2):60-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular imaging of brain tumors: a bridge between clinical and molecular medicine?
  • As the research on cellular changes has shed invaluable light on the pathophysiology and biochemistry of brain tumors, clinical and experimental use of molecular imaging methods is expanding and allows quantitative assessment.
  • Molecular imaging sets forth to probe the molecular abnormalities that are the basis of disease rather than to visualize the end effects of these molecular alterations and, therefore, provides different additional biochemical or molecular information about primary brain tumors compared to histological methods "classical" neuroradiological diagnostic studies.
  • Common clinical indications for molecular imaging contain primary brain tumor diagnosis and identification of the metabolically most active brain tumor reactions (differentiation of viable tumor tissue from necrosis), prediction of treatment response by measurement of tumor perfusion, or ischemia.
  • The interesting key question remains not only whether the magnitude of biochemical alterations demonstrated by molecular imaging reveals prognostic value with respect to survival, but also whether it identifies early disease and differentiates benign from malignant lesions.
  • [MeSH-major] Brain Neoplasms / diagnosis. Neurons / diagnostic imaging. Positron-Emission Tomography / methods
  • [MeSH-minor] Animals. Cell- and Tissue-Based Therapy. Disease Models, Animal. Disease Progression. Humans. Molecular Probes. Neoplasm Staging. Radiography

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2003 Jun;111(11):1620-9 [12782662.001]
  • [Cites] Nucl Med Commun. 2003 Nov;24(11):1149-54 [14569169.001]
  • [Cites] Acta Radiol. 1989 Mar-Apr;30(2):121-8 [2493795.001]
  • [Cites] J Nucl Med. 1993 Jan;34(1):12-7 [8418251.001]
  • [Cites] Ann Neurol. 2003 Oct;54(4):479-87 [14520660.001]
  • [Cites] Expert Opin Biol Ther. 2004 Feb;4(2):145-55 [14998774.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 2;92 (3):205-16 [10655437.001]
  • [Cites] Neurol Med Chir (Tokyo). 1998 Jun;38(6):342-7; discussion 347-8 [9689817.001]
  • [Cites] Mol Imaging. 2002 Oct;1(4):309-35 [12926228.001]
  • [Cites] Cancer Res. 2003 Dec 1;63(23):8122-5 [14678964.001]
  • [Cites] J Comput Assist Tomogr. 1993 Sep-Oct;17 (5):681-7 [8370819.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1018-25 [15877226.001]
  • [Cites] Nucl Med Biol. 2004 Feb;31(2):179-89 [15013483.001]
  • [Cites] Neoplasia. 2005 Jun;7(6):623-9 [16036113.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):653-9 [15711980.001]
  • [Cites] Expert Rev Neurother. 2006 May;6(5):723-30 [16734520.001]
  • [Cites] Neuroradiology. 1998 Feb;40(2):103-8 [9541920.001]
  • [Cites] Cancer Res. 2002 Mar 15;62(6):1862-7 [11912166.001]
  • [Cites] Cancer. 2002 Sep 15;95(6):1376-86 [12216107.001]
  • [Cites] J Neurooncol. 2004 May;68(1):1-9 [15174514.001]
  • [Cites] Acta Neurol Scand. 2005 Feb;111(2):75-83 [15644065.001]
  • [Cites] J Nucl Med. 1991 Apr;32(4):726-8 [2013813.001]
  • [Cites] Ann Neurol. 1998 Oct;44(4):691-5 [9778271.001]
  • [Cites] Bone Marrow Transplant. 2002 Jul;30(2):103-11 [12132049.001]
  • [Cites] J Natl Cancer Inst. 2005 Mar 16;97(6):414-6 [15770001.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2004 Nov;31(11):1530-8 [15378285.001]
  • [Cites] Clin Cancer Res. 2004 Feb 15;10(4):1255-62 [14977823.001]
  • [Cites] Cancer Res. 2000 Jan 15;60(2):417-24 [10667596.001]
  • [Cites] Blood. 2003 Jul 1;102(1):53-9 [12609836.001]
  • [Cites] Cancer Res. 2003 Nov 15;63(22):7571-4 [14633668.001]
  • [Cites] Hum Gene Ther. 2003 Feb 10;14(3):277-97 [12639307.001]
  • [Cites] Radiology. 2001 May;219(2):316-33 [11323453.001]
  • [Cites] Neoplasia. 2000 Nov-Dec;2(6):491-5 [11228541.001]
  • [Cites] J Neurooncol. 1992 Feb;12 (2):159-65 [1560262.001]
  • [Cites] J Clin Oncol. 1990 Jul;8(7):1277-80 [2358840.001]
  • [Cites] Dev Neurosci. 2004 Mar-Aug;26(2-4):118-30 [15711055.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12846-51 [11070094.001]
  • [Cites] Acta Neurochir (Wien). 2000;142(1):1-15 [10664370.001]
  • [Cites] J Neuropathol Exp Neurol. 2003 Feb;62(2):111-26 [12578221.001]
  • [Cites] Acta Radiol Suppl. 1986;369:157-60 [2980438.001]
  • [Cites] J Neurochem. 1977 May;28(5):897-916 [864466.001]
  • [Cites] J Neurosurg. 2005 Sep;103(3):498-507 [16235683.001]
  • [Cites] J Comput Assist Tomogr. 1992 Jan-Feb;16(1):62-8 [1729308.001]
  • [Cites] Chest. 2003 Aug;124(2):608-13 [12907550.001]
  • [Cites] J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9 [9776413.001]
  • [Cites] Neurosurgery. 1994 Jun;34(6):994-1002; discussion 1002 [8084410.001]
  • [Cites] J Biol Chem. 1999 Jul 9;274(28):19745-51 [10391916.001]
  • [Cites] Neurology. 1982 Dec;32(12 ):1323-9 [6983044.001]
  • [Cites] Cancer Res. 2002 Oct 15;62(20):5657-63 [12384520.001]
  • [Cites] Lancet. 2001 Sep 1;358(9283):727-9 [11551583.001]
  • [Cites] NeuroRx. 2005 Apr;2(2):333-47 [15897954.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):64-74 [16111573.001]
  • [Cites] Radiology. 1995 Oct;197(1):221-6 [7568827.001]
  • [Cites] J Neuropathol Exp Neurol. 2002 Jan;61(1):58-63 [11829344.001]
  • [Cites] Acta Otolaryngol. 1997 Jul;117(4):482-9 [9288200.001]
  • [Cites] J Comput Assist Tomogr. 1993 Jul-Aug;17 (4):509-61 [8392523.001]
  • [Cites] J Nucl Med. 2006 Mar;47(3):393-403 [16513607.001]
  • [Cites] J Nucl Med. 2005 Mar;46(3):450-4 [15750158.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13513-8 [14595012.001]
  • [Cites] NMR Biomed. 2003 Apr;16(2):67-76 [12730947.001]
  • [Cites] Eur J Nucl Med. 2001 Dec;28(12 ):1851-72 [11734927.001]
  • [Cites] Invest Radiol. 1987 May;22(5):360-71 [3496318.001]
  • [Cites] Mol Imaging Biol. 2004 Jul-Aug;6(4):239-69 [15262239.001]
  • [Cites] J Neurooncol. 2004 Jul;68(3):207-15 [15332323.001]
  • [Cites] Neurosurg Rev. 1999 Dec;22(4):210-4 [10682929.001]
  • [Cites] Mol Imaging Biol. 2004 May-Jun;6(3):139-48 [15193248.001]
  • [Cites] Eur J Nucl Med. 1997 Sep;24(9):1149-55 [9283109.001]
  • [Cites] Magn Reson Med. 2004 May;51(5):893-9 [15122670.001]
  • [Cites] J Nucl Med. 2001 Mar;42(3):467-75 [11337525.001]
  • [Cites] J Neurosurg. 1994 Sep;81(3):427-36 [8057151.001]
  • [Cites] J Nucl Med. 2000 Apr;41(4):661-81 [10768568.001]
  • [Cites] Cancer Res. 2001 Mar 1;61(5):1781-5 [11280722.001]
  • [Cites] Cancer Res. 2004 Sep 1;64(17):6101-8 [15342393.001]
  • [Cites] Neurosurgery. 1997 Apr;40(4):789-803; discussion 803-4 [9092853.001]
  • [Cites] J Nucl Med. 2003 Dec;44(12 ):1962-9 [14660722.001]
  • [Cites] Nat Biotechnol. 2003 Apr;21(4):405-13 [12652311.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9300-5 [11481488.001]
  • [Cites] J Neurooncol. 2000 Sep;49(2):157-63 [11206011.001]
  • [Cites] Q J Nucl Med. 1995 Sep;39(3):243-9 [7552947.001]
  • [Cites] J Nucl Med. 2005 Dec;46(12 ):1948-58 [16330557.001]
  • [Cites] J Neurosurg. 1999 Nov;91(5):797-803 [10541237.001]
  • [Cites] Eur J Nucl Med. 1997 Apr;24(4):428-34 [9096095.001]
  • [Cites] Ann Oncol. 2002;13 Suppl 4:139-43 [12401680.001]
  • [Cites] Cancer Res. 2004 Apr 1;64(7):2572-9 [15059914.001]
  • [Cites] J Nucl Med. 1997 Sep;38(9):1459-62 [9293808.001]
  • [Cites] J Neurooncol. 1999 Jul;43(3):231-6 [10563428.001]
  • [Cites] Neurosurgery. 2005 Sep;57(3):505-11; discussion 505-11 [16145529.001]
  • [Cites] Mol Ther. 2004 Nov;10(5):916-28 [15509509.001]
  • [Cites] Leukemia. 2002 Feb;16(2):260-7 [11840293.001]
  • [Cites] Int J Cancer. 2001 Jun 20;96(3):191-7 [11410888.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2004 May;31(5):740-51 [15014901.001]
  • [Cites] J Cereb Blood Flow Metab. 1984 Jun;4(2):212-23 [6609929.001]
  • [Cites] Blood. 2005 Jan 1;105(1):420-5 [15331444.001]
  • [Cites] J Comput Assist Tomogr. 1983 Dec;7(6):1062-6 [6415134.001]
  • [Cites] J Neuroimaging. 2003 Jul;13(3):269-71 [12889176.001]
  • [Cites] J Nucl Med. 1994 Jul;35(7):1162-6 [8014676.001]
  • [Cites] Nat Med. 2000 Apr;6(4):447-50 [10742153.001]
  • [Cites] Neurosurgery. 1993 Jul;33(1):28-33 [8355844.001]
  • [Cites] J Cereb Blood Flow Metab. 1991 May;11(3):485-91 [2016357.001]
  • [Cites] AJR Am J Roentgenol. 1988 Jan;150(1):189-97 [3257119.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2003 Jun;30(6):868-73 [12692687.001]
  • [Cites] J Magn Reson Imaging. 2004 Apr;19(4):389-96 [15065161.001]
  • [Cites] Exp Cell Res. 2005 Jun 10;306(2):323-9 [15925587.001]
  • [Cites] Radiology. 1993 Jan;186(1):45-53 [8380108.001]
  • [Cites] J Nucl Med. 1999 Mar;40(3):381-6 [10086699.001]
  • [Cites] Neurosurgery. 1989 Nov;25(5):720-8 [2586726.001]
  • [Cites] Nat Med. 2004 Nov;10(11):1257-60 [15502845.001]
  • [Cites] Cancer Res. 2004 Aug 1;64(15):5347-54 [15289341.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):43-52 [10924970.001]
  • [Cites] J Nucl Med. 1991 Jul;32(7):1338-46 [1906093.001]
  • [Cites] J Nucl Med. 1997 Sep;38(9):1369-74 [9293789.001]
  • [Cites] Cancer Res. 2001 Apr 1;61(7):2983-95 [11306477.001]
  • [Cites] J Neurooncol. 2003 Sep;64(3):227-37 [14558598.001]
  • [Cites] Trends Neurosci. 2005 Mar;28(3):120-6 [15749164.001]
  • [Cites] J Clin Oncol. 2001 Jan 1;19(1):265-72 [11134222.001]
  • [Cites] Clin Nucl Med. 1996 Sep;21(9):720-5 [8879874.001]
  • [Cites] J Nucl Med. 1998 May;39(5):778-85 [9591574.001]
  • [Cites] J Neurosurg. 2003 May;98 (5):1056-64 [12744366.001]
  • [Cites] Nervenarzt. 2003 Dec;74(12):1134-6 [14647916.001]
  • [Cites] Neurobiol Dis. 2004 Apr;15(3):437-48 [15056451.001]
  • [Cites] Radiographics. 1992 Mar;12 (2):269-79 [1561416.001]
  • [Cites] Stereotact Funct Neurosurg. 1997;69(1-4 Pt 2):129-35 [9711745.001]
  • [Cites] Eur J Nucl Med. 1996 May;23 (5):583-6 [8698067.001]
  • [Cites] Pediatr Neurosurg. 1997 Mar;26(3):144-56 [9419031.001]
  • [Cites] J Nucl Med. 2004 Nov;45(11):1939-45 [15534066.001]
  • [Cites] Cancer. 1994 Nov 15;74(10):2836-42 [7954245.001]
  • [Cites] Cancer. 1988 Sep 15;62(6):1074-8 [3261622.001]
  • [Cites] J Neurosurg. 1985 Jun;62(6):816-22 [2987440.001]
  • (PMID = 17203238.001).
  • [ISSN] 1536-1632
  • [Journal-full-title] Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging
  • [ISO-abbreviation] Mol Imaging Biol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Molecular Probes
  • [Number-of-references] 135
  •  go-up   go-down


74. Shigeishi H, Yamaguchi S, Mizuta K, Nakakuki K, Fujimoto S, Amagasa T, Kamata N: Amphiregulin induces proliferative activities in osseous dysplasia. J Dent Res; 2009 Jun;88(6):563-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Amphiregulin induces proliferative activities in osseous dysplasia.
  • Human osseous dysplasia (OD) is a benign fibro-osseous neoplasm of periodontal ligament origin in which normal bone is replaced with fibrous connective tissue containing abnormal bone or cementum.
  • [MeSH-major] Fibrous Dysplasia of Bone / metabolism. Glycoproteins / physiology. Intercellular Signaling Peptides and Proteins / physiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19587163.001).
  • [ISSN] 1544-0591
  • [Journal-full-title] Journal of dental research
  • [ISO-abbreviation] J. Dent. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / AREG protein, human; 0 / Amphiregulin; 0 / EGF Family of Proteins; 0 / Glycoproteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Recombinant Proteins
  •  go-up   go-down


75. Wang Q, Huang LL, Yue MG, Qin SL, Wang Y, Nie YX, Zhang CQ, Liang TJ, Zhao YM: [18F-FDG imaging by coincidence circuit SPECT with low-dose CT in preoperative assessment of pulmonary lesions]. Zhonghua Zhong Liu Za Zhi; 2006 Dec;28(12):924-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To assess the clinical diagnostic value of 18F-FDG imaging by coincidence circuit SPECT with low-dose CT in differential diagnosis of pulmonary lesions and mediastinal lymph node involvement, which can not be definitely diagnosed based on regular CT image in patients with non-small-cell lung cancer (NSCLC).
  • RESULTS: Final pathologic diagnoses of these patients were 36 malignancies consisting of 20 adenocarcinomas, 12 squamous cell carcinomas, 3 small cell carcinomas and I large cell carcinoma; 12 benign tumors including 6 pneumonias, 2 tuberculosis, 2 hamatomas, 1 cyst and 1 neurofibroma.
  • Correct diagnosis were made in 34 malignancies and 6 false positive lesions were excluded based on morphology and 18F-FDG uptake status of the lesion.
  • Furthermore, extrathoracic metastases which were not showed on previous CT image in 4 patients including one in the adrenal gland and 3 in the bone were detected by 18F-FDG imaging.
  • The sensitivity, specificity and accuracy of the 18F-FDG imaging for differentiating malignant tumor from benign was 94.4%, 50.0% and 83.3%, respectively.
  • CONCLUSION: 18F-FDG imaging by coincidence circuit SPECT with low-dose CT is quite helpful in differential diagnosis for patient with undetermined lesion on regular CT image, but it is limited for staging of lung cancer in the patients with non-small cell lung cancer.
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / diagnosis. Fluorodeoxyglucose F18. Lung Neoplasms / diagnosis. Pneumonia / diagnosis. Tomography, Emission-Computed, Single-Photon / methods
  • [MeSH-minor] Adult. Aged. Diagnosis, Differential. Female. Humans. Lung / pathology. Lung / radiography. Lung / radionuclide imaging. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Preoperative Care. Radiation Dosage. Radiopharmaceuticals. Retrospective Studies. Sensitivity and Specificity. Tomography, X-Ray Computed. Tuberculosis, Pulmonary / diagnosis. Tuberculosis, Pulmonary / radiography. Tuberculosis, Pulmonary / radionuclide imaging

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Pneumonia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17533745.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


76. Pimenta FJ, Gontijo Silveira LF, Tavares GC, Silva AC, Perdigão PF, Castro WH, Gomez MV, Teh BT, De Marco L, Gomez RS: HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncol; 2006 Aug;42(7):735-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ossifying fibroma (OF) is a benign neoplasm related to bone characterized by a progressive enlargement of the affected jaw.
  • Recently, the candidate tumor suppressor gene HRPT2 was identified and alterations in this gene were related with the Hyperparathyroidism-jaw tumor syndrome that is characterized by parathyroid adenoma or carcinoma, fibro-osseous lesions (mainly OF) of the jaws, and renal lesions.
  • Tumour and blood samples were obtained from 3 patients with OF and one with juvenile ossifying fibroma (JOF).
  • RT-PCR amplification was performed to analyze HRPT2 mRNA expression and only wild-type HRPT2 transcript was found in all tumours.
  • [MeSH-major] Fibroma, Ossifying / genetics. Genes, Tumor Suppressor. Mandibular Neoplasms / genetics. Tumor Suppressor Proteins / genetics
  • [MeSH-minor] Adolescent. Adult. Female. Gene Expression. Humans. Male. Middle Aged. Mutation. RNA, Messenger / genetics. RNA, Neoplasm / genetics. Reverse Transcriptase Polymerase Chain Reaction / methods

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16458039.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CDC73 protein, human; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / Tumor Suppressor Proteins
  •  go-up   go-down


77. Wang Z, Guo Z, Li J, Li XD, Sang HX: Functional outcomes and complications of reconstruction of the proximal humerus after intra-articular tumor resection. Orthop Surg; 2010 Feb;2(1):19-26
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Functional outcomes and complications of reconstruction of the proximal humerus after intra-articular tumor resection.
  • OBJECTIVE: To evaluate functional outcomes and complications of reconstruction of the proximal humerus after intra-articular tumor resection.
  • METHODS: Twenty-five patients who underwent Malawer I type resection and reconstruction of the proximal humerus for treatment of malignant or invasive benign tumors from August 1999 to August 2005 were evaluated.
  • A variety of reconstructive procedures, including modular tumor prosthesis, osteoarticular allograft, and allograft-prosthetic composite (APC), were performed after resection of tumor.
  • The modified Musculoskeletal Tumor Society (MSTS) evaluation system was used to assess limb functional outcome.
  • RESULTS: The study group consisted of 10 male and 15 female patients, among which there were 20 malignant and 5 benign tumors.
  • [MeSH-major] Arthroplasty, Replacement / methods. Bone Neoplasms / surgery. Humerus / surgery. Neoplasms, Connective Tissue / surgery. Shoulder Joint / surgery
  • [MeSH-minor] Adolescent. Adult. Child. Female. Humans. Lymphoma / mortality. Lymphoma / pathology. Lymphoma / surgery. Male. Middle Aged. Neoplasm Metastasis. Neoplasm Recurrence, Local. Postoperative Complications / epidemiology. Recovery of Function. Retrospective Studies. Treatment Outcome. Young Adult

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 Tianjin Hospital and Blackwell Publishing Asia Pty Ltd.
  • (PMID = 22009903.001).
  • [ISSN] 1757-7861
  • [Journal-full-title] Orthopaedic surgery
  • [ISO-abbreviation] Orthop Surg
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


78. Poffyn B, Sys G, Van Maele G, Van Hoorebeke L, Forsyth R, Verstraete K, Uyttendaele D: Radiographic analysis of extracorporeally irradiated autografts. Skeletal Radiol; 2010 Oct;39(10):999-1008
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To analyse the long-term radiographic findings of intercalary, pure osteoarticular, and composite bone grafts in patients with primary bone sarcoma who were treated by reimplantation of the bone as an orthotopic autograft.
  • MATERIALS AND METHODS: For this observational clinical study, 107 patients who presented with 108 malignant or locally aggressive benign bone tumours were treated by resection, extracorporeal irradiation (300 Gy), and reimplantation and fixation of the autograft.
  • Bone healing features were evaluated with the International Society of Limb Salvage (ISOLS) graft evaluation method, which assesses fusion, resorption, fracture, graft shortening, fixation, subluxation, joint narrowing, and subchondral bone.
  • CONCLUSION: This reconstruction technique is valid for the three methods described; bone stock is retained and, once the graft has healed, it behaves as normal bone.
  • [MeSH-major] Bone Neoplasms / surgery. Bone Transplantation / diagnostic imaging. Bone Transplantation / methods. Sarcoma / surgery

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pediatr Radiol. 1999 Oct;29(10 ):785-93 [10525789.001]
  • [Cites] Clin Orthop Relat Res. 2007 Jun;459:54-9 [17545759.001]
  • [Cites] Skeletal Radiol. 1995 May;24(4):283-6 [7644942.001]
  • [Cites] J Bone Joint Surg Br. 2007 Apr;89(4):521-6 [17463123.001]
  • [Cites] Int Orthop. 1997;21(5):291-7 [9476157.001]
  • [Cites] Clin Orthop Relat Res. 2008 Aug;466(8):1897-904 [18543052.001]
  • [Cites] Int Orthop. 2002;26(3):174-8 [12073112.001]
  • [Cites] Radiol Clin North Am. 1995 Mar;33(2):391-400 [7871175.001]
  • [Cites] J Bone Joint Surg Am. 1991 Sep;73(8):1119-22 [1890114.001]
  • [Cites] J Bone Joint Surg Br. 2006 Aug;88(8):1022-6 [16877600.001]
  • [Cites] Clin Orthop Relat Res. 2005 Jun;(435):36-42 [15930919.001]
  • [Cites] J Bone Joint Surg Br. 1988 May;70(3):348-53 [3163694.001]
  • [Cites] Skeletal Radiol. 2003 Aug;32(8):454-61 [12827315.001]
  • [Cites] J Bone Joint Surg Am. 2008 Jun;90(6):1265-71 [18519320.001]
  • [Cites] Int Orthop. 2006 Dec;30(6):452-7 [16967279.001]
  • [Cites] J Bone Joint Surg Am. 1990 Sep;72(8):1137-43 [2398083.001]
  • [Cites] J Bone Joint Surg Am. 1991 Sep;73(8):1123-42 [1890115.001]
  • [Cites] Acta Orthop Scand. 1997 Aug;68(4):392-5 [9310047.001]
  • [Cites] Clin Orthop Relat Res. 2005 Sep;438:71-9 [16131872.001]
  • [Cites] Clin Orthop Relat Res. 1999 Nov;(368):196-206 [10613169.001]
  • (PMID = 20703876.001).
  • [ISSN] 1432-2161
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


79. Fabi A, Nuzzo C, Vidiri A, Ciccarese M, Felici A, Cattani F, Cognetti F: Bone and lung metastases from intracranial meningioma. Anticancer Res; 2006 Sep-Oct;26(5B):3835-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bone and lung metastases from intracranial meningioma.
  • Fifteen percent of intracranial tumors are represented by meningiomas.
  • Meningioma is usually a benign neoplasm; malignant histology is rare and represents about 2-10% with a 43% incidence of metastasis.
  • A rare case of a woman with a relapse of intracranial meningioma in the right frontal lobe who subsequently developed simultaneous bone and intrapulmonary metastases is reported.
  • [MeSH-major] Bone Neoplasms / secondary. Brain Neoplasms / pathology. Lung Neoplasms / secondary. Meningioma / pathology


80. Zafatayeff-Hasbani S, Ducou Le Pointe H, Josset P, Damsin JP, Montagne JP: Intra-articular recurrence of benign chondroblastoma with articular involvement at initial presentation--a case report. Eur J Pediatr Surg; 2006 Aug;16(4):291-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intra-articular recurrence of benign chondroblastoma with articular involvement at initial presentation--a case report.
  • Intra-articular and soft tissue recurrence occurred after treatment consisting of curettage and bone grafting.
  • [MeSH-major] Bone Neoplasms / pathology. Chondrosarcoma / pathology. Tibia
  • [MeSH-minor] Adolescent. Curettage. Epiphyses / pathology. Humans. Knee Joint. Male. Neoplasm Recurrence, Local. Neoplasm Seeding. Soft Tissue Neoplasms / pathology

  • Genetic Alliance. consumer health - Chondroblastoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16981100.001).
  • [ISSN] 0939-7248
  • [Journal-full-title] European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift für Kinderchirurgie
  • [ISO-abbreviation] Eur J Pediatr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


81. Ortakoglu K, Akcam T, Sencimen M, Karakoc O, Ozyigit HA, Bengi O: Osteochondroma of the mandible causing severe facial asymmetry: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 May;103(5):e21-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteochondroma is one of the most common benign tumors of bone.
  • The aim of the present study is to emphasize the importance of stereolithographic models in planning tumor surgery and how it affects the treatment planning, operation time and prognosis.
  • Based on the model evaluation, the tumor was conservatively resected and the condyle left intact, leaving no sequelae.

  • Genetic Alliance. consumer health - Osteochondroma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17331758.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. Simmons C, Amir E, Dranitsaris G, Clemons M, Wong B, Veith R, Cole DE: Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancer. Anticancer Res; 2009 Jul;29(7):2707-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Bisphosphonates (BPs) are considered the standard of care in metastatic breast cancer (MBC) patients with bone metastases.
  • These results were compared to a historical control group of 420 patients without bone or mineral disease who were matched for gender, age, baseline renal function and season of seological testing.
  • CONCLUSION: In MBC patients with prolonged BP use, there appears to be a state of hyperparathyroidism similar to that seen with BP use in benign bone disease.
  • [MeSH-major] Breast Neoplasms / metabolism. Calcium / metabolism. Diphosphonates / therapeutic use. Neoplasm Metastasis / drug therapy


83. Lin SP, Fang YC, Chu DC, Chang YC, Hsu CI: Characteristics of cranial aneurysmal bone cyst on computed tomography and magnetic resonance imaging. J Formos Med Assoc; 2007 Mar;106(3):255-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characteristics of cranial aneurysmal bone cyst on computed tomography and magnetic resonance imaging.
  • Aneurysmal bone cysts are benign bone tumors that most commonly occur in people younger than 30 years.
  • The tumor was soft, fragile, and pulsatile during surgery.
  • The patient was treated with en bloc resection of the tumor with cranioplasty.

  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17389172.001).
  • [ISSN] 0929-6646
  • [Journal-full-title] Journal of the Formosan Medical Association = Taiwan yi zhi
  • [ISO-abbreviation] J. Formos. Med. Assoc.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


84. Fu K, Meng ZB, Li J, Li HC: [Repairing the defect of benign bone tumor with the coralline hydroxyapatite]. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 May;33(5):421-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Repairing the defect of benign bone tumor with the coralline hydroxyapatite].
  • OBJECTIVE: To observe the clinical effect of repairing bone defectin post-operation benign tumor with coralline hydroxyapatite(CHAP).
  • The CHAP was implanted into the lesion after bone tumor curettage to 25 patients.
  • The sizes of bone defect ranged from 0.8 cm x 0.5 cm x 0.5 cm to 10 cm x 3.5 cm x 2 cm.
  • X-ray showed that there was osteogenesis at the cortical bone 1 month post-operation.
  • There is corresponding synchronization between bone formation with CHAP biodegradation.
  • The CHAP is an excellent bone defect repairing material.
  • [MeSH-major] Bone Neoplasms / surgery. Ceramics. Giant Cell Tumor of Bone / surgery. Hydroxyapatites. Prostheses and Implants
  • [MeSH-minor] Adolescent. Adult. Aged. Bone Cysts / surgery. Bone Regeneration. Bone Substitutes. Child. Female. Femur / surgery. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18544846.001).
  • [ISSN] 1672-7347
  • [Journal-full-title] Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
  • [ISO-abbreviation] Zhong Nan Da Xue Xue Bao Yi Xue Ban
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Bone Substitutes; 0 / Hydroxyapatites; 0 / coralline hydroxyapatite
  •  go-up   go-down


85. Gelabert-González M, García-Allut A: Spinal extradural angiolipoma: report of two cases and review of the literature. Eur Spine J; 2009 Mar;18(3):324-35
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Spinal angiolipomas are benign uncommon neoplasm composed of mature lipocytes admixed with abnormal blood vessels.
  • They account for only 0.04-1.2% of all spinal tumors.
  • Prior to diagnosis 40.6% of the patients had weakness of the lower limbs.
  • The interval between the initial symptoms and tumor diagnosis ranged from 1 day to 17 years (mean 20.2 months).
  • Spinal angiolipomas are tumors containing angiomatous and lipomatous tissue, predominantly located in the mid-thoracic region.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Neurosurg. 1993;7(3):328 [8338660.001]
  • [Cites] No Shinkei Geka. 1993 Oct;21(10):959-62 [8413813.001]
  • [Cites] Eur Spine J. 2006 Jun;15(6):1025-8 [16172903.001]
  • [Cites] J Neurosurg. 1947 Sep;4(5):476-81 [20260249.001]
  • [Cites] J Neurosurg. 1970 Oct;33(4):466-70 [4990564.001]
  • [Cites] Conn Med. 2000 May;64(5):267-9 [10860233.001]
  • [Cites] Br J Neurosurg. 2000 Oct;14(5):471-2 [11198773.001]
  • [Cites] Neurochirurgie. 2000 Dec;46(6):523-533 [11148405.001]
  • [Cites] J Neurooncol. 2000 Sep;49(3):219-30 [11212901.001]
  • [Cites] Can J Neurol Sci. 2001 Feb;28(1):82-8 [11252303.001]
  • [Cites] J Neuroradiol. 2001 Dec;28(4):253-6 [11924141.001]
  • [Cites] Neurocirugia (Astur). 2002 Aug;13(4):321-5 [12355656.001]
  • [Cites] Childs Nerv Syst. 2002 Dec;18(12):725-8 [12483360.001]
  • [Cites] Arq Neuropsiquiatr. 2003 Jun;61(2A):269-73 [12806510.001]
  • [Cites] Acta Neurochir (Wien). 2004 Mar;146(3):299-302; discussion 302 [15015054.001]
  • [Cites] Spinal Cord. 2004 May;42(5):313-6 [15123997.001]
  • [Cites] J Spinal Disord Tech. 2004 Oct;17(5):456-61 [15385889.001]
  • [Cites] J Bone Joint Surg Am. 1966 Sep;48(6):1111-24 [5917698.001]
  • [Cites] Lille Med. 1969 Mar;14(3):311-5 [5360833.001]
  • [Cites] Arch Putti Chir Organi Mov. 1969;24:70-85 [4929766.001]
  • [Cites] Rev Neurol (Paris). 1971 May;124(5):385-91 [4331311.001]
  • [Cites] J Spinal Disord. 1995 Aug;8(4):324-7 [8547775.001]
  • [Cites] Arq Neuropsiquiatr. 1995 Sep;53(3-B):659-61 [8585827.001]
  • [Cites] Can Assoc Radiol J. 1996 Feb;47(1):51-3 [8548470.001]
  • [Cites] Aust N Z J Surg. 1996 Mar;66(3):194-6 [8639145.001]
  • [Cites] AJNR Am J Neuroradiol. 1996 Apr;17(4):713-9 [8730192.001]
  • [Cites] Childs Nerv Syst. 1996 Jun;12(6):346-9 [8816302.001]
  • [Cites] Acta Neurochir (Wien). 1996;138(11):1311-9 [8980735.001]
  • [Cites] Clin Neuropathol. 1997 Mar-Apr;16(2):107-10 [9101114.001]
  • [Cites] Am J Surg Pathol. 1997 Apr;21(4):441-4 [9130991.001]
  • [Cites] Spine (Phila Pa 1976). 1997 Oct 1;22(19):2304-8 [9346153.001]
  • [Cites] Spine (Phila Pa 1976). 1998 Feb 1;23(3):391-4 [9507632.001]
  • [Cites] Clin Neuropathol. 1999 Mar-Apr;18(2):93-8 [10192705.001]
  • [Cites] Neuroradiology. 1999 Aug;41(8):584-7 [10447570.001]
  • [Cites] J Spinal Disord. 1999 Aug;12(4):353-6 [10451053.001]
  • [Cites] Br J Neurosurg. 1999 Feb;13(1):25-9 [10492681.001]
  • [Cites] Br J Neurosurg. 1999 Feb;13(1):30-40 [10492682.001]
  • [Cites] Br J Surg. 1951 Jul;39(153):1-7 [14858818.001]
  • [Cites] Riv Neurol. 1958 Nov-Dec;28(6):667-76 [13646511.001]
  • [Cites] Arch Dermatol. 1960 Dec;82:924-31 [13716236.001]
  • [Cites] JAMA. 1962 Aug 18;181:610-2 [14468492.001]
  • [Cites] J Neurosurg. 2005 Aug;103(2 Suppl):166-9 [16370284.001]
  • [Cites] Neurol Med Chir (Tokyo). 2006 Mar;46(3):157-60 [16565587.001]
  • [Cites] J Neurosurg. 1974 Jul;41(1):100-3 [4834199.001]
  • [Cites] Cancer. 1974 Sep;34(3):720-7 [4855281.001]
  • [Cites] J Neurosurg Sci. 1974 Apr-Jun;18(2):136-41 [4465410.001]
  • [Cites] Rev Clin Esp. 1977 Sep 30;146(6):395-6 [594449.001]
  • [Cites] Acta Neurol (Napoli). 1977 Nov-Dec;32(6):850-3 [605836.001]
  • [Cites] Acta Neurochir (Wien). 1978;45(1-2):187-93 [742436.001]
  • [Cites] J Med Assoc Thai. 1979 Aug;62(8):457-60 [490074.001]
  • [Cites] N Engl J Med. 1980 Jan 3;302(1):36 [6892516.001]
  • [Cites] Neurochirurgia (Stuttg). 1980 May;23(3):117-20 [7412970.001]
  • [Cites] Surg Neurol. 1980 Jul;14(1):77-9 [7414490.001]
  • [Cites] Surg Neurol. 1981 Feb;15(2):110-3 [7245002.001]
  • [Cites] Acta Neurochir (Wien). 1981;58(1-2):115-9 [7282455.001]
  • [Cites] J Neurosurg. 1982 Feb;56(2):267-9 [7054436.001]
  • [Cites] No Shinkei Geka. 1982 Mar;10(3):313-6 [7099374.001]
  • [Cites] Neurosurgery. 1982 Nov;11(5):674-7 [7155332.001]
  • [Cites] Neurochirurgia (Stuttg). 1984 Jan;27(1):28-30 [6700819.001]
  • [Cites] Neurosurgery. 1985 Mar;16(3):406-11 [3982624.001]
  • [Cites] Ann Pathol. 1984 Dec;4(5):365-9 [6534389.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1985;406(2):253-9 [3923701.001]
  • [Cites] Spine (Phila Pa 1976). 1986 Jan-Feb;11(1):47-8 [3704780.001]
  • [Cites] Neurochirurgia (Stuttg). 1986 Mar;29(2):63-6 [3713958.001]
  • [Cites] Surg Neurol. 1986 Nov;26(5):473-86 [3764652.001]
  • [Cites] Spine (Phila Pa 1976). 1986 Jul-Aug;11(6):623-5 [3787328.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1987 Aug;50(8):1057-9 [3655813.001]
  • [Cites] J Comput Assist Tomogr. 1987 Nov-Dec;11(6):1104-6 [3680705.001]
  • [Cites] Surg Neurol. 1988 Mar;29(3):243-5 [3344472.001]
  • [Cites] J Natl Med Assoc. 1988 Mar;80(3):347-9 [3351973.001]
  • [Cites] AJR Am J Roentgenol. 1989 May;152(5):1087-96 [2705343.001]
  • [Cites] Neurosurgery. 1990 Aug;27(2):315-8 [2385353.001]
  • [Cites] Surg Neurol. 1990 Sep;34(3):173-8 [2201098.001]
  • [Cites] J Comput Assist Tomogr. 1991 Jan-Feb;15(1):83-5 [1987206.001]
  • [Cites] AJNR Am J Neuroradiol. 1991 Jul-Aug;12(4):744-5 [1882757.001]
  • [Cites] Spine (Phila Pa 1976). 1992 Jun;17(6):719-24 [1626307.001]
  • [Cites] No Shinkei Geka. 1992 Oct;20(10):1085-9 [1407344.001]
  • [Cites] Neurosurgery. 1992 Oct;31(4):758-64; discussion 764 [1407465.001]
  • [Cites] Br J Neurosurg. 1992;6(5):481-3 [1449672.001]
  • [Cites] J Neurosurg. 1993 Feb;78(2):280-6 [8421211.001]
  • [Cites] Surg Neurol. 1993 Jan;39(1):49-52 [8451720.001]
  • [Cites] Neurochirurgia (Stuttg). 1993 Mar;36(2):63-5 [8483512.001]
  • [Cites] Neurol Med Chir (Tokyo). 1993 May;33(5):316-9 [7687040.001]
  • (PMID = 19127373.001).
  • [ISSN] 1432-0932
  • [Journal-full-title] European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
  • [ISO-abbreviation] Eur Spine J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 99
  • [Other-IDs] NLM/ PMC2899409
  •  go-up   go-down


86. Kinnunen IA, Schrey A, Laine J, Aitasalo K: The use of pedicled temporal musculoperiosteal flap with or without free calvarial bone graft in maxillary reconstructions. Eur Arch Otorhinolaryngol; 2010 Aug;267(8):1299-304
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The use of pedicled temporal musculoperiosteal flap with or without free calvarial bone graft in maxillary reconstructions.
  • The aim of this study was to evaluate the suitability of pedicled temporal musculoperiosteal flap (PTMF) and free calvarial bone graft for the reconstruction of maxillary defects.
  • In this retrospective series, 34 patients operated on from 1995 to 2006 at Turku University Central Hospital because of defects of maxilla reconstructed using PTMF with or without free calvarial bone graft were evaluated.
  • The diagnosis, the indication for surgery, the location and staging of the tumours, and the type of radiotherapy used were reviewed.
  • Of the patients, 32 had been operated on due to a malignant tumour, one due to a benign tumour and one due to posttraumatic palatal defect.
  • Preoperative radiotherapy (n = 14), preoperative chemoradiotherapy (n = 2) or postoperative radiotherapy (n = 11) had been used in the tumour group.
  • As a reconstructive method, PTMF had been used with (n = 21) or without (n = 13) free calvarial bone graft.
  • The use of free calvarial bone graft did not have a significant effect on flap survival.
  • The application of PTMF with or without free calvarial bone graft for reconstruction of limited palatal and maxillary defects appears to be feasible.
  • [MeSH-major] Bone Transplantation. Maxillary Neoplasms / surgery. Palatal Neoplasms / surgery. Surgical Flaps
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Combined Modality Therapy. Female. Follow-Up Studies. Graft Survival / physiology. Humans. Male. Middle Aged. Neoadjuvant Therapy. Neoplasm Staging. Postoperative Complications / diagnostic imaging. Postoperative Complications / mortality. Postoperative Complications / surgery. Reoperation. Retrospective Studies. Survival Rate. Tissue and Organ Harvesting / methods. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Eur Arch Otorhinolaryngol. 2013 Sep;270(10):2779-81 [23824316.001]
  • [CommentIn] Eur Arch Otorhinolaryngol. 2013 Sep;270(10):2783 [23857025.001]
  • [Cites] J Oral Maxillofac Surg. 1997 Nov;55(11):1200-6 [9371107.001]
  • [Cites] Plast Reconstr Surg (1946). 1948 Jan;3(1):66-72 [18921673.001]
  • [Cites] Lancet Oncol. 2006 Mar;7(3):249-58 [16510334.001]
  • [Cites] Int J Oral Maxillofac Surg. 1997 Oct;26(5):369-73 [9327289.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):862-9 [11448364.001]
  • [Cites] Laryngoscope. 1998 Feb;108(2):215-9 [9473070.001]
  • [Cites] J Craniomaxillofac Surg. 2005 Feb;33(1):1-7 [15694142.001]
  • [Cites] J Surg Oncol. 2006 Nov 1;94(6):522-31 [17061275.001]
  • [Cites] Plast Reconstr Surg. 2007 Dec;120(7):1963-72; discussion 1973-4 [18090760.001]
  • [Cites] J Craniomaxillofac Surg. 1987 Dec;15(6):332-41 [3323241.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2005 Oct;131(10):879-85 [16230590.001]
  • [Cites] J Craniomaxillofac Surg. 2001 Dec;29(6):337-43 [11777351.001]
  • [Cites] J Craniomaxillofac Surg. 1991 Aug;19(6):235-42 [1939669.001]
  • [Cites] ANZ J Surg. 2006 Apr;76(4):267-9 [16681547.001]
  • [Cites] Br J Oral Maxillofac Surg. 2002 Jun;40(3):183-90 [12054706.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Feb;61(2):174-81 [12618993.001]
  • [Cites] J Craniomaxillofac Surg. 1995 Aug;23(4):203-14 [7560105.001]
  • [Cites] Plast Reconstr Surg. 1998 Nov;102(6):1874-84; discussion 1885-7 [9810982.001]
  • (PMID = 20232072.001).
  • [ISSN] 1434-4726
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


87. Yamaguchi T, Watanabe-Ishiiwa H, Suzuki S, Igarashi Y, Ueda Y: Incipient chordoma: a report of two cases of early-stage chordoma arising from benign notochordal cell tumors. Mod Pathol; 2005 Jul;18(7):1005-10
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incipient chordoma: a report of two cases of early-stage chordoma arising from benign notochordal cell tumors.
  • Chordomas are rare malignant bone tumors primarily involving both ends of the axial skeleton that present as destructive bone lesions with a large soft tissue mass.
  • However, recent studies suggest the possibility that chordomas arise from benign notochordal cell tumors.
  • The coccygeal tumors were composed of intraosseous and extraosseous infiltrative lesions.
  • The intraosseous lesions consisted of both benign notochordal cell tumor and incipient chordoma.
  • In addition, two other small benign notochordal cell tumors were found at a different level in case 1.
  • It is conceivable that pre-existing intraosseous benign notochordal cell tumors transform into incipient chordoma and then extend through the cortex into the surrounding soft tissue.
  • The incidence of incipient chordoma appears much higher than expected because chordomas are rare tumors with an incidence of one case per 1 000 000 persons per year.
  • [MeSH-minor] Aged. Aged, 80 and over. Carcinoma, Hepatocellular / complications. Coccyx. Fatal Outcome. Humans. Liver Neoplasms / complications. Male. Neoplasm Staging. Notochord / pathology. Prostatic Neoplasms / complications

  • Genetic Alliance. consumer health - Chordoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15803192.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


88. Meller I, Weinbroum A, Bickels J, Dadia S, Nirkin A, Merimsky O, Issakov J, Flusser G, Marouani N, Cohen N, Kollender Y: Fifteen years of bone tumor cryosurgery: a single-center experience of 440 procedures and long-term follow-up. Eur J Surg Oncol; 2008 Aug;34(8):921-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fifteen years of bone tumor cryosurgery: a single-center experience of 440 procedures and long-term follow-up.
  • BACKGROUND: This summary of a single center's extensive cumulative experience in bone tumor cryosurgery assesses the long-term outcome of bone conservation surgery in which adjuvant cryosurgery plays a pivotal role.
  • Two-thirds of the series comprised a variety of primary benign-aggressive and low-grade malignant lesions, and one-third were primary high-grade and metastatic bone tumors.
  • The anatomical locations included almost every bone of the skeleton.
  • Two methods of bone cryosurgery were used: Marcove's "open" direct-pour system using liquid nitrogen (1988-1997) and Meller's "closed" argon-based system (1998 to the present).
  • The functional outcome for the 372 patients with no evidence of disease was almost 100% "good" and "excellent" (American Musculo-skeletal Tumor Society System).
  • CONCLUSIONS: Bone cryosurgery is a safe and effective limb-, joint- and even epiphysis-sparing surgical technique in suitable types of bone tumors, temporarily or permanently obviating the need for resection surgery.
  • [MeSH-major] Bone Neoplasms / surgery. Cryosurgery. Neoplasm Recurrence, Local

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18158228.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


89. Yadia S, Randazzo CG, Malik S, Gressen E, Chasky M, Kenyon LC, Ratliff JK: Pilomatrix carcinoma of the thoracic spine: case report and review of the literature. J Spinal Cord Med; 2010;33(3):272-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONTEXT: Pilomatrixoma is a common head and neck neoplasm in children.
  • The patient underwent resection of the axillary mass and spinal reconstruction of the fracture; the pathology was consistent with synchronous benign pilomatrixomas.
  • [MeSH-major] Bone Neoplasms / secondary. Carcinoma / secondary. Hair Diseases. Pilomatrixoma / pathology. Skin Neoplasms / pathology. Spine / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Hair Problems.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pak Med Assoc. 2000 Jun;50(6):197-9 [10979629.001]
  • [Cites] J Plast Reconstr Aesthet Surg. 2009 Dec;62(12):e574-7 [19027384.001]
  • [Cites] Otolaryngol Head Neck Surg. 2001 Nov;125(5):510-5 [11700451.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2001;13(5):386-9 [11716236.001]
  • [Cites] Am J Dermatopathol. 2001 Oct;23(5):394-401 [11801770.001]
  • [Cites] Am J Dermatopathol. 2002 Apr;24(2):139-43 [11979074.001]
  • [Cites] J Cutan Pathol. 2004 Apr;31(4):330-5 [15005691.001]
  • [Cites] Cancer. 1980 May 1;45(9):2368-73 [7379033.001]
  • [Cites] Cancer. 1984 Jul 15;54(2):370-2 [6722751.001]
  • [Cites] Arch Pathol Lab Med. 1986 Jul;110(7):660-3 [3755030.001]
  • [Cites] J Surg Oncol. 1986 Oct;33(2):112-4 [3762182.001]
  • [Cites] Neuroradiology. 1989;31(2):196-8 [2747902.001]
  • [Cites] Cancer. 1993 Apr 15;71(8):2491-8 [8453573.001]
  • [Cites] Histopathology. 1993 Oct;23(4):385-6 [7993397.001]
  • [Cites] Am J Dermatopathol. 1994 Apr;16(2):196-200 [8030776.001]
  • [Cites] Cancer. 1996 Apr 1;77(7):1311-4 [8608508.001]
  • [Cites] Eur J Cancer. 1999 Mar;35(3):433-7 [10448295.001]
  • [Cites] Strahlenther Onkol. 2006 Dec;182(12):727-32 [17149580.001]
  • [Cites] J Am Acad Dermatol. 2001 Feb;44(2 Suppl):358-61 [11174415.001]
  • (PMID = 20737803.001).
  • [ISSN] 1079-0268
  • [Journal-full-title] The journal of spinal cord medicine
  • [ISO-abbreviation] J Spinal Cord Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 21
  • [Other-IDs] NLM/ PMC2920123
  •  go-up   go-down


90. Guo Z, Wang Z, Li J, Li XD: [Reconstruction with a new type of combined reconstruction following excision of periacetabular tumors]. Zhonghua Wai Ke Za Zhi; 2008 Jun 15;46(12):895-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Reconstruction with a new type of combined reconstruction following excision of periacetabular tumors].
  • OBJECTIVE: To evaluate the reconstructive effect of a new pattern of combined reconstruction after periacetabular tumor resections.
  • METHODS: Between March 2001 and March 2007, tumor resections and new pattern of combined reconstructions which consisted of screw-rod system, acetabular reinforcement shell, antibiotic cement and total hip arthroplasty techniques were performed in 23 patients with periacetabular tumors.
  • Seventeen patients had primary malignant tumors including 7 chondrosarcomas, 4 osteosarcomas, 2 Ewing sarcomas, 2 malignant fibrohistiocytomas, 1 malignant Schwannomas, and 1 synovial sarcoma.
  • Other primary tumors were 2 giant cell tumors and 1 aggressive osteoblastoma.
  • Three metastatic bone tumors were also included in this study, and the original sites were thyroid, breast, and ovary.
  • Three primary benign bone tumors belonged to stage III.
  • 8 months (range, 9-73 months) in the patients with primary tumors.
  • CONCLUSIONS: This new combined reconstruction is an effective way to rebuild pelvic ring and maintain hip function with low complication rate after periacetabular tumor resections.
  • [MeSH-major] Acetabulum. Bone Neoplasms / surgery. Reconstructive Surgical Procedures / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Arthroplasty, Replacement, Hip. Bone Screws. Female. Follow-Up Studies. Humans. Male. Middle Aged. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19035146.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


91. Rougraff BT: Bone graft alternatives in the treatment of benign bone tumors. Instr Course Lect; 2005;54:505-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bone graft alternatives in the treatment of benign bone tumors.
  • Most bone grafting procedures are done during spinal fusion and to treat patients with skeletal trauma.
  • Very few studies have addressed the bone grafting of skeletal defects after benign bone tumor excision.
  • Contained defects have been treated with autogenous bone grafts, fresh-frozen allografts, freeze-dried allografts, demineralized bone matrix, and ceramic materials.
  • Additionally, bone morphogenetic proteins may provide a future treatment option for bone tumor reconstruction.
  • [MeSH-major] Bone Neoplasms / surgery. Bone Transplantation / methods
  • [MeSH-minor] Bone Substitutes. Ceramics. Humans. Tissue Preservation / methods. Transplantation, Homologous

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15948475.001).
  • [ISSN] 0065-6895
  • [Journal-full-title] Instructional course lectures
  • [ISO-abbreviation] Instr Course Lect
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bone Substitutes
  • [Number-of-references] 30
  •  go-up   go-down


92. Rozeman LB, Szuhai K, Schrage YM, Rosenberg C, Tanke HJ, Taminiau AH, Cleton-Jansen AM, Bovée JV, Hogendoorn PC: Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations. Cancer; 2006 Jul 15;107(2):380-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Enchondromas are benign lesions that can occur as solitary tumors or multiple tumors (Ollier disease) and may be precursors of central chondrosarcomas.
  • Recurrent chondrosarcomas can be of a higher grade compared with primary tumors, suggesting possible progression.
  • METHODS: Genome-wide array-comparative genomic hybridization (CGH) was used to investigate copy number changes in enchondromas and central chondrosarcomas to elucidate both primary genetic events and the events related to tumor progression.
  • RESULTS: Genomic imbalances were rare in enchondromas and in grade I chondrosarcomas, whereas they were frequent in high-grade tumors.
  • The authors identified 22 chromosome regions that were imbalanced in > or =25% of tumors, and 3 of those regions were located on chromosome 12 (12p13, 12p11.21-p11.23, and 12q13, containing among others the PTPRF-interacting protein-binding protein 1 (PPFIBP1) gene.
  • CONCLUSIONS: In the current study the authors identified genomic regions and new candidate genes (RPS6, CDK4, and PPFIBP1) that were associated with tumor progression and prognosis in patients with high-grade chondrosarcomas.
  • [MeSH-major] Bone Neoplasms / genetics. Chondrosarcoma / genetics. Chromosome Aberrations. Chromosomes, Human, Pair 12 / genetics. Cyclin-Dependent Kinase 4 / genetics. Ribosomal Protein S6 / genetics
  • [MeSH-minor] Adaptor Proteins, Signal Transducing. Carrier Proteins / genetics. Chromosome Deletion. Chromosomes, Human, Pair 6 / genetics. Enchondromatosis / genetics. Female. Genes, Neoplasm. Genomic Instability. Humans. Male. Neoplasm Staging. Nucleic Acid Hybridization. Oligonucleotide Array Sequence Analysis. Prognosis


93. Al-Otaibi M, Lach B, Al Shail E: December 2004: one-year-old girl with aggressive skull tumor. Brain Pathol; 2005 Apr;15(2):171-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] December 2004: one-year-old girl with aggressive skull tumor.
  • December 2004. Twelve-month old girl presented with recurrent subcutaneous lesion in the left parietal region, one year after excision of a "benign" tumor.
  • An MRI demonstrated left temporo-parietal skull tumor infiltrating the soft tissue, surrounding craniotomy flap, and extending to the brain parenchyma.
  • Biopsy revealed biphasic neoplasm displaying nests of poorly differentiated neuroblastic cells positive for synaptophysin and pigmented cuboidal epithelioid cell positive for keratins, epithelial membrane antigen and MHB-45.
  • Interestingly, cell with the neuroblastic immunophenotype displayed 80% nuclear MIB-1 reactivity indicating that the aggressiveness of the neoplasm was confined mostly to this pattern of differentiation.
  • The overall histological features are consistent with a rare malignant variant of a melanotic neuroectodermal tumor of infancy.
  • [MeSH-major] Neoplasm Recurrence, Local / pathology. Neuroectodermal Tumor, Melanotic / pathology. Parietal Bone / pathology. Skull Neoplasms / pathology
  • [MeSH-minor] Brain Neoplasms / secondary. Diagnosis, Differential. Fatal Outcome. Female. Humans. Immunohistochemistry. Infant. Magnetic Resonance Imaging. Soft Tissue Neoplasms / secondary. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15912891.001).
  • [ISSN] 1015-6305
  • [Journal-full-title] Brain pathology (Zurich, Switzerland)
  • [ISO-abbreviation] Brain Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Switzerland
  •  go-up   go-down


94. Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, Milanezi F, Paredes J, Costa JL, Schmitt F: Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer; 2010;10:483
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
  • METHODS: We have used a cohort comprising normal breast, benign mammary lesions, carcinomas in situ and invasive carcinomas and assessed the expression of the VDR, CYP27B1 and CYP24A1 by immunohistochemistry.
  • The VDR was frequently expressed in benign lesions (93.5%) and its levels of expression were diminished in invasive tumours (56.2%).
  • CYP27B1 expression is slightly lower in invasive carcinomas (44.6%) than in benign lesions (55.8%).
  • In contrast, CYP24A1 expression was augmented in carcinomas (56.0% in in situ and 53.7% in invasive carcinomas) when compared with that in benign lesions (19.0%).
  • CONCLUSIONS: From this study, we conclude that there is a deregulation of the Vitamin D signalling and metabolic pathways in breast cancer, favouring tumour progression.
  • Thus, during mammary malignant transformation, tumour cells lose their ability to synthesize the active form of Vitamin D and respond to VDR-mediated Vitamin D effects, while increasing their ability to degrade this hormone.
  • [MeSH-minor] Biomarkers, Tumor / genetics. Biomarkers, Tumor / metabolism. Blotting, Western. Carcinoma, Ductal, Breast / metabolism. Carcinoma, Ductal, Breast / pathology. Carcinoma, Intraductal, Noninfiltrating / metabolism. Carcinoma, Intraductal, Noninfiltrating / pathology. Cohort Studies. Disease Progression. Female. Gene Expression Profiling. Humans. Immunoenzyme Techniques. Metabolic Networks and Pathways. Neoplasm Staging. Oligonucleotide Array Sequence Analysis. Prognosis. RNA, Messenger / genetics. Reverse Transcriptase Polymerase Chain Reaction. Signal Transduction. Vitamin D3 24-Hydroxylase

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Vitamin D.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Exp Metastasis. 1994 May;12(3):195-202 [8194194.001]
  • [Cites] Cancer Res. 1991 Jan 1;51(1):239-44 [1846309.001]
  • [Cites] J Histochem Cytochem. 1998 Nov;46(11):1335-7 [9774633.001]
  • [Cites] Am J Clin Nutr. 2004 Dec;80(6 Suppl):1721S-4S [15585794.001]
  • [Cites] Clin Cancer Res. 2005 May 1;11(9):3579-86 [15867263.001]
  • [Cites] Am J Physiol Renal Physiol. 2005 Jul;289(1):F8-28 [15951480.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2370-6 [16214919.001]
  • [Cites] Virchows Arch. 2005 Oct;447(4):688-94 [16012853.001]
  • [Cites] J Steroid Biochem Mol Biol. 2005 Oct;97(1-2):153-64 [16111884.001]
  • [Cites] Breast Cancer Res. 2005;7(6):R980-6 [16280049.001]
  • [Cites] Science. 2006 Apr 14;312(5771):233-6 [16614213.001]
  • [Cites] J Steroid Biochem Mol Biol. 2006 Aug;100(4-5):184-92 [16828283.001]
  • [Cites] Ann Oncol. 2007 Mar;18(3):581-92 [17287242.001]
  • [Cites] Virchows Arch. 2007 Jan;450(1):73-80 [17123107.001]
  • [Cites] Nat Rev Cancer. 2007 Sep;7(9):684-700 [17721433.001]
  • [Cites] J Histochem Cytochem. 2007 Dec;55(12):1257-64 [17875655.001]
  • [Cites] Proc Nutr Soc. 2008 May;67(2):115-27 [18412986.001]
  • [Cites] J Cell Biochem. 2008 Nov 1;105(4):980-8 [18767073.001]
  • [Cites] Anticancer Res. 2009 Jan;29(1):155-7 [19331145.001]
  • [Cites] Int J Cancer. 2009 Sep 15;125(6):1328-33 [19437538.001]
  • [Cites] Mol Pharmacol. 2009 Oct;76(4):702-9 [19570947.001]
  • [Cites] J Cell Biochem. 1999 Dec 15;75(4):640-51 [10572247.001]
  • [Cites] Cell. 2000 Jan 7;100(1):57-70 [10647931.001]
  • [Cites] Nat Genet. 2000 Jun;25(2):144-6 [10835626.001]
  • [Cites] Circ Res. 2000 Aug 4;87(3):214-20 [10926872.001]
  • [Cites] Clin Cancer Res. 2000 Aug;6(8):3371-9 [10955825.001]
  • [Cites] Nature. 2000 Aug 17;406(6797):747-52 [10963602.001]
  • [Cites] Methods. 2001 Dec;25(4):402-8 [11846609.001]
  • [Cites] Histochem J. 2002 Jan-Feb;34(1-2):35-40 [12365798.001]
  • [Cites] Mol Cell Endocrinol. 2003 Feb 28;200(1-2):67-80 [12644300.001]
  • [Cites] Clin Cancer Res. 2004 Aug 15;10(16):5367-74 [15328174.001]
  • [Cites] Lancet. 1979 Dec 22-29;2(8156-8157):1335-6 [92676.001]
  • [Cites] Cancer Res. 1984 Apr;44(4):1677-81 [6322984.001]
  • [Cites] Cancer Res. 1987 Dec 15;47(24 Pt 1):6793-9 [2824042.001]
  • [Cites] Science. 1988 May 13;240(4854):889-95 [3283939.001]
  • [Cites] J Clin Endocrinol Metab. 1988 Sep;67(3):607-13 [2842365.001]
  • [Cites] Am J Clin Pathol. 1988 Sep;90(3):233-9 [2458030.001]
  • [Cites] J Bone Miner Res. 1998 Mar;13(3):325-49 [9525333.001]
  • (PMID = 20831823.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / RNA, Messenger; 0 / Receptors, Calcitriol; 1406-16-2 / Vitamin D; EC 1.14.- / 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; EC 1.14.- / Steroid Hydroxylases; EC 1.14.13.126 / CYP24A1 protein, human; EC 1.14.13.126 / Vitamin D3 24-Hydroxylase
  • [Other-IDs] NLM/ PMC2945944
  •  go-up   go-down


95. Nishida K, Doita M, Kawahara N, Tomita K, Kurosaka M: Total en bloc spondylectomy in the treatment of aggressive osteoblastoma of the thoracic spine. Orthopedics; 2008 Apr;31(4):403
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Osteoblastoma is an uncommon, benign osteoblastic tumor accounting for <1% of all primary bone tumors.
  • Aggressive osteoblastoma is a variant of osteoblastoma and is considered to be a borderline or intermediate osteoblastic tumor, first defined by Dorfman and Weiss in 1984.
  • As a rare tumor, its true incidence and distribution are not clearly known.
  • Treatment options for such a highly recurrent benign tumor are discussed.
  • [MeSH-major] Laminectomy / methods. Neoplasm Recurrence, Local / prevention & control. Osteoblastoma / surgery. Spinal Neoplasms / surgery. Thoracic Vertebrae / surgery

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19292265.001).
  • [ISSN] 0147-7447
  • [Journal-full-title] Orthopedics
  • [ISO-abbreviation] Orthopedics
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Park YK, Kim EJ, Kim SW: Osteoblastoma of the ethmoid sinus. Skeletal Radiol; 2007 May;36(5):463-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An osteoblastoma is a benign bone tumor that most often occurs in the vertebral column and the long bones of the extremities.
  • A mixture of ground glass opacity and dense bone was present.
  • Histologically, the lesion was composed of proliferating osteoblasts along with small trabeculae of woven bone and rich vascular fibrous stroma.
  • [MeSH-major] Ethmoid Sinus / pathology. Ethmoid Sinus / surgery. Osteoblastoma / diagnosis. Osteoblastoma / surgery. Paranasal Sinus Neoplasms / diagnosis. Paranasal Sinus Neoplasms / surgery

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Otolaryngol. 1979 Oct;105(10 ):623-5 [485933.001]
  • [Cites] An Esp Pediatr. 1997 Jan;46(1):83-4 [9082899.001]
  • [Cites] J Clin Pathol. 1993 Nov;46(11):1024-9 [8254089.001]
  • [Cites] Ann Laringol Otol Rinol Faringol. 1965;64(6):768-77 [5218396.001]
  • [Cites] J Comput Tomogr. 1985 Oct;9(4):347-50 [4053663.001]
  • [Cites] Laryngorhinootologie. 1991 May;70(5):275-7 [2064707.001]
  • [Cites] Klin Oczna. 1975 Mar;45(3):247-51 [1117656.001]
  • [Cites] Otolaryngol Pol. 2004;58(3):649-52 [15311621.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 1996 Dec 5;38(1):89-95 [9119598.001]
  • [Cites] Am J Clin Pathol. 1975 Mar;63(3):391-6 [1115044.001]
  • [Cites] Rhinology. 1983 Dec;21(4):373-5 [6665425.001]
  • [Cites] Cancer. 1974 May;33(5):1289-305 [4207295.001]
  • [Cites] Otolaryngol Pol. 1974;28(5):575-9 [4419075.001]
  • [Cites] J Neurosurg. 1997 Oct;87(4):625-8 [9322852.001]
  • [Cites] Cancer. 1985 Jan 15;55(2):416-26 [3855268.001]
  • [Cites] Otolaryngol Head Neck Surg. 1980 Jul-Aug;88(4):397-402 [6821422.001]
  • [Cites] J Laryngol Otol. 1993 Aug;107(8):737-9 [8409731.001]
  • [Cites] Skeletal Radiol. 2002 Mar;31(3):179-82 [11935205.001]
  • [Cites] J Laryngol Otol. 1978 Apr;92(4):337-45 [641417.001]
  • [Cites] Hum Pathol. 1994 Feb;25(2):117-34 [8119712.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 1976 Oct-Nov;93(10-11):661-8 [1027351.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1985;408(2-3):297-305 [3936268.001]
  • [Cites] AJR Am J Roentgenol. 2004 May;182(5):1343-4 [15868703.001]
  • [Cites] J Laryngol Otol. 1997 Sep;111(9):865-8 [9373556.001]
  • [Cites] Ann Pathol. 1985;5(2):131-6 [4041187.001]
  • [Cites] Head Neck Surg. 1983 Sep-Oct;6(1):605-9 [6629798.001]
  • [Cites] J Laryngol Otol. 1986 Feb;100(2):229-32 [3950490.001]
  • (PMID = 17265159.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


97. Tsai CY, Wei FC, Chang YL, Chen YY, Chen CT: Vastus lateralis muscle flap used for reconstruction of the maxilla after radical resection of recurrent ameloblastoma. Chang Gung Med J; 2006 May-Jun;29(3):331-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Maxillary ameloblastoma is a benign odontogenic neoplasm.
  • Simultaneous reconstruction was performed with an iliac crest bone graft for the orbital floor, and a vastus lateralis muscle flap for obliteration of the maxillary sinus and repair the oral and nasal cavities.
  • The conventional iliac bone graft supported by a well vascularized muscle eventually survived and provided a good functional and cosmetic result.
  • [MeSH-major] Ameloblastoma / surgery. Maxilla / surgery. Maxillary Neoplasms / surgery. Neoplasm Recurrence, Local / surgery. Surgical Flaps

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16924896.001).
  • [ISSN] 2072-0939
  • [Journal-full-title] Chang Gung medical journal
  • [ISO-abbreviation] Chang Gung Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China (Republic : 1949- )
  •  go-up   go-down


98. Liang X, Jiang D, Ni W: [Clinical observation on nano-hydroxyapatite and polyamide 66 composite in repairing bone defect due to benign bone tumor]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Aug;21(8):785-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical observation on nano-hydroxyapatite and polyamide 66 composite in repairing bone defect due to benign bone tumor].
  • OBJECTIVE: To observe the clinical effect and safety of the nano-hydroxyapatite/polyamide 66 (n-HA/PA66) composite in repairing the bone defects due to benign bone tumors.
  • METHODS: From January 2003 to May 2005, 38 patients (21 males, 16 females; age, 19-58 years, averaged 38.5 years) with the bone defects due to benign bone tumors were treated with the n-HA/PA66 grains.
  • Among the 37 patients, 11 had fibrous dysplasia, 14 had bone cyst, 10 had giant cell tumor of the bone (Grade I ), and 2 had enchondroma.
  • The tumors ranged in size from 1.0 cm x 0.7 cm x 0.4 cm to 10.0 cm x 4.0 cm x 3.0 cm, with the location of the proximal femur in 12 patients, the distal femur in 7, the proximal tibia in 9, the proximal humerus in 5, the phalanges of the finger in 2, the metacarpal bone in 1, and the calcaneus in 1.
  • All the benign bone tumors underwent the curettage treatment, and then the tumor cavities were filled up with the n-HA/PA66 grains.
  • The incision healing, local inflammatory reaction, rejection, toxic reaction, tumor cavity healing, and function recovery of the limbs were all observed after operation.
  • CONCLUSION: The n-HA/PA66 grains have great biological safety, good biocompatibility, and good bone conduction, which are good materials for the bone repair and reconstruction, and can be safely, and effectively used for repairing the bone defects due to benign bone tumors.
  • [MeSH-major] Bone Neoplasms / surgery. Bone Substitutes. Hydroxyapatites. Nylons
  • [MeSH-minor] Adult. Biocompatible Materials. Bone Cysts / surgery. Female. Follow-Up Studies. Giant Cell Tumor of Bone / surgery. Humans. Male. Middle Aged. Nanostructures. Reconstructive Surgical Procedures / methods. Treatment Outcome. Wound Healing. Young Adult

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17882867.001).
  • [ISSN] 1002-1892
  • [Journal-full-title] Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
  • [ISO-abbreviation] Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biocompatible Materials; 0 / Bone Substitutes; 0 / Hydroxyapatites; 0 / Nylons
  •  go-up   go-down


99. Singh M, Gupta KC: Surgical treatment of odontogenic keratocyst by enucleation. Contemp Clin Dent; 2010 Oct;1(4):263-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although odontogenic keratocysts (OKCs) are benign, they are often locally destructive and tend to recur after conservative surgical treatment.
  • Histologic examination is essential for diagnosis since the appearances on roentgenograms and at operation usually do not reveal the true nature of the lesion.
  • Decompression causes a reduction in the cyst volume with new bone formation so that the structures impinged upon (e.g., teeth, nerves) are completely free.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22114435.001).
  • [ISSN] 0976-2361
  • [Journal-full-title] Contemporary clinical dentistry
  • [ISO-abbreviation] Contemp Clin Dent
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3220151
  • [Keywords] NOTNLM ; Gorlin syndrome / benign cystic neoplasm / odontogenic keratocyst / radicular cyst
  •  go-up   go-down


100. Roy S, Dobson P, Henry L: An isolated osteochondroma with underlying non-Hodgkin's lymphoma of bone. J Bone Joint Surg Br; 2005 Oct;87(10):1423-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An isolated osteochondroma with underlying non-Hodgkin's lymphoma of bone.
  • Osteochondroma is the most common benign bone tumour.
  • We report a case of an isolated osteochondroma which appeared benign on clinical and plain radiographic examination but routine histological analysis revealed non-Hodgkin's lymphoma in the underlying bone.
  • This association has not previously been reported and the case emphasises the importance of routine histological analysis, even if a lesion appears benign.
  • [MeSH-major] Bone Neoplasms / pathology. Lymphoma, Large B-Cell, Diffuse / pathology. Neoplasms, Multiple Primary / pathology. Osteochondroma / pathology

  • Genetic Alliance. consumer health - Osteochondroma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16189321.001).
  • [ISSN] 0301-620X
  • [Journal-full-title] The Journal of bone and joint surgery. British volume
  • [ISO-abbreviation] J Bone Joint Surg Br
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down






Advertisement